<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta charset="utf-8" />
		<title>BCSC1819_S06_C28_p385-416_final</title>
		<link href="BCSC1819_S06_C28_p385-416_final-web-resources/css/idGeneratedStyles.css" rel="stylesheet" type="text/css" />
	</head>
	<body id="BCSC1819_S06_C28_p385-416_final" lang="en-US">
		<div id="_idContainer000" class="Basic-Text-Frame">
			<p class="chapter-number"><span class="cn-chap">Chapter </span>28</p>
			<p class="chapter-title">Ocular Manifestations of Systemic Disease</p>
			<p class="body-text--no-indent-">This chapter focuses on select systemic disorders with multiple types of ocular involvement. Systemic disorders with 1 primary ocular abnormality are discussed in other chapters in this volume. Often, the ophthalmologist can help to make the correct systemic diagnosis.</p>
			<p class="h1">Diseases due to Chromosomal Abnormalities</p>
			<div id="Chapt28_Top1">
			<p class="body-text--no-indent-">Abnormalities in chromosomal number (aneuploidy: trisomy or monosomy), structure (duplications, deletions, translocations, inversions, or rings), or type (autosomal or sex chromosome) occur in approximately 1&#160;in 150 live births. <span class="xref-table">&#173;Table&#160;28-1</span> lists select chromosomal abnormalities commonly associated with ocular findings. Also see BCSC Section&#160;2, <span class="italic">Fundamentals and Princi&#173;ples of Ophthalmology,</span> Chapter&#160;6.</p>
			</div>
			<p class="h1">Inborn Errors of Metabolism</p>
			<div id="Chapt28_Top2">
			<p class="body-text--no-indent-">Inborn errors of metabolism are estimated to occur in 1&#160;in 1400 births and are typically caused by biallelic mutations. Ocular findings can result from direct toxicity of abnormal metabolic products, accumulation of abnormal (or normal) metabolites, errors of synthetic pathways, or deficient production of energy. The age at onset of ocular manifestations of inborn errors of metabolism varies. <span class="xref-table">&#173;Table&#160;28-2</span> summarizes the common ophthalmic manifestations of select conditions. Also see Chapter&#160;21. Following are examples of ocular structural abnormalities secondary to metabolic disorders:</p>
			<ul>
				<li class="bullet-list-first ParaOverride-1">Corneal clouding or deposits: certain mucopolysaccharidoses (<span class="xref-figure">Fig 28-1</span>), cystinosis (<span class="xref-figure">Fig 28-2</span>), Schnyder corneal dystrophy (<span class="xref-figure">Fig 28-3</span>)</li>
				<li class="bullet-list-mid ParaOverride-1">Corneal pseudodendritic ulcerations: tyrosinemia</li>
				<li class="bullet-list-mid ParaOverride-1">Cataracts: diabetes mellitus, galactosemia, Smith-&#173;Lemli-&#173;Opitz syndrome, cerebrotendinous xanthomatosis (<span class="xref-figure">Fig 28-4</span>)</li>
				<li class="bullet-list-mid ParaOverride-1">Lens luxation or subluxation: homocystinuria (<span class="xref-figure">Fig 28-5</span>)</li>
				<li class="bullet-list-mid ParaOverride-1">Retinal degeneration: peroxisomal disorders (Zellweger syndrome, Refsum disease), lysosomal disorders (eg, neuronal ceroid lipofuscinosis), mitochondrial disorders (eg, Kearns-&#173;Sayre syndrome [<span class="xref-figure">Fig 28-6</span>])</li>
				<li class="bullet-list-last ParaOverride-1">Central macular cherry-&#173;red spot: GM<span class="subscript _idGenCharOverride-1">2</span> gangliosidosis type I (Tay-&#173;Sachs disease) and type II (Sandhoff disease), Niemann-&#173;Pick disease. The cherry-&#173;red spot dis&#173;appears over time as the intumescent ganglion cells die and optic atrophy develops. Therefore, the absence of a cherry-&#173;red spot should not be used to rule out a diagnosis, especially in older &#173;children.</li>
			</ul>
			<p class="body-text">In some disorders, early metabolic control greatly decreases the risk of ocular and systemic sequelae. Therefore, early recognition of metabolic disorders and timely referral to a ge&#173;ne&#173;ticist are essential. The ophthalmologist can play a key role in the early identification of certain treatable metabolic disorders, examples of which are galactosemia, classic homocystinuria (Chapter&#160;23), cystinosis (Chapter 21), certain mucopolysaccharidoses, and cerebrotendinous xanthomatosis (Chapter&#160;23).</p>
			<p class="reference--journal--single">Poll-&#173;The BT, Maillette de Buy Wenniger-&#173;Prick CJ. The eye in metabolic diseases: clues to diagnosis. <span class="italic">Eur J Paediatr Neurol.</span> 2011;15(3):197–204.</p>
			</div>
			<p class="h1">Familial Oculorenal Syndromes</p>
			<div id="Chapt28_Top3">
			<p class="h2-h1">Lowe Syndrome</p>
			<p class="body-text--no-indent-">Lowe (oculocerebrorenal) syndrome is due to hemizygous <span class="italic">OCRL</span> mutation and is characterized by both bilateral congenital cataract and glaucoma. Pupils are typically miotic. The lenses are small and thick and may exhibit posterior lenticonus. In carrier &#173;mothers, they show radially oriented punctate snowflake opacities. Systemic findings include congenital hypotonia, cognitive impairment, and infantile renal tubulopathy (Fanconi type) with resultant aminoaciduria, metabolic acidosis, proteinuria, and rickets.</p>
			<p class="h2">Alport Syndrome</p>
			<p class="body-text--no-indent-">Alport syndrome shows dif&#173;fer&#173;ent inheritance patterns, but X-&#173;linked inheritance is the&#160;most common. Ocular findings include anterior lenticonus or anterior subcapsular cataract, posterior polymorphous corneal dystrophy, and fleck retinopathy. Alport syndrome is a basement membrane disease that can include progressive renal failure and&#160;deafness.</p>
			<p class="h2">Ciliopathies</p>
			<p class="body-text--no-indent-">Ciliopathies are disorders of organ-&#173;specific or systemic cilia dysfunction. Nonmotile cilia have a variety of specialized functions, such as cell signaling, detection of chemical gradients, and intracellular transport. Ret&#173;i&#173;nal involvement is frequent in ciliopathies &#173;because the junction between inner and outer segments of the photoreceptor cell is a modified nonmotile cilium. When a child has a retinopathy secondary to a systemic ciliopathy, the most common &#173;later organ dysfunction is renal. The possibility of systemic ciliopathy&#160;should be considered in all &#173;children with early-&#173;onset ret&#173;i&#173;nal dystrophy.</p>
			<p class="body-text">Systemic ciliopathies include Senior-&#173;L<span class="accent">ø</span>ken syndrome (retinopathy, &#173;later renal dysfunction), Bardet-&#173;Biedl syndrome (retinopathy, polydactyly [<span class="xref-figure">Fig 28-7</span>], obesity, &#173;later renal dysfunction), Alstr<span class="accent">ö</span>m syndrome (retinopathy, cardiomyopathy, obesity, &#173;later renal dysfunction), and Joubert syndrome (retinopathy, oculomotor apraxia, developmental delay, characteristic magnetic resonance imaging [MRI] findings [<span class="xref-figure">Fig 28-8</span>], &#173;later renal dysfunction).</p>
			</div>
			<p class="h1">Neuro-Oculocutaneous Syndromes</p>
			<div id="Chapt28_Top4">
			<p class="body-text--no-indent-">Neuro-&#173;oculocutaneous syndromes (phakomatoses) are characterized by systemic hamartomas of the eye, central ner&#173;vous system (CNS), and skin. Diagnosis is clinical, according to the latest published consensus criteria. Ocular involvement is frequent and can help confirm the specific diagnosis. An overview of &#173;these conditions is provided in <span class="xref-table">&#173;Table&#160;28-3</span>.</p>
			<p class="h2">Neurofibromatosis Type 1</p>
			<p class="body-text--no-indent-">Neurofibromatosis type 1 (NF1) is characterized by multiple melanocytic and neuroglial lesions. See &#173;Table&#160;28-3 for a list of common features.</p>
			<p class="h3">Melanocytic lesions</p>
			<p class="body-text--no-indent-"><span class="italic">Caf</span><span class="accent_italic">é</span><span class="italic">-&#173;au-&#173;lait spots</span>, the most common cutaneous expression of NF1, are uniformly hyperpigmented macules of varying size (<span class="xref-figure">Fig 28-9</span>). Some are usually pres&#173;ent at birth; the number and size increase during the first de&#173;cade of life. Unaffected individuals may have 1–3 caf<span class="accent">é</span>-&#173;au-&#173;lait spots, but greater numbers are rare except in association with NF1. Melanocytic lesions of the uveal tract are also common.</p>
			<p class="body-text"><span class="italic">Lisch nodules</span> are small (usually &lt;1&#160;mm), sharply demarcated, dome-&#173;shaped excrescences of the iris (<span class="xref-figure">Fig 28-10</span>). Lisch nodules most often develop between ages 5 and 10&#160;years and are pres&#173;ent in nearly all adults with NF1. Multiple flat choroidal lesions 1–2 times the size of the optic disc are common. &#173;These lesions are difficult to visualize by conventional fundus examination, but near-&#173;infrared reflectance imaging has a high sensitivity for detection. Melanocytic lesions in NF1 do not affect vision.</p>
			<p class="h3">Neuroglial lesions</p>
			<p class="body-text--no-indent-"><span class="italic">Nodular cutaneous</span> and <span class="italic">subcutaneous neurofibromas,</span> or <span class="italic">fibroma molluscum,</span> are by far&#160;the most common lesions of neuroglial origin. They typically develop in late childhood.</p>
			<p class="body-text"><span class="italic">Plexiform neurofibromas</span> are seen in approximately 30% of cases. &#173;These are extensive, soft subcutaneous swellings with indistinct margins, often with hyperpigmentation or hypertrichosis of the overlying skin. Hypertrophy of under&#173;lying soft tissue and bone (regional gigantism) is often pres&#173;ent. Plexiform neurofibromas develop earlier than nodular lesions, are frequently evident in infancy or childhood, and may cause severe disfigurement and functional impairment. Approximately 10% involve the face, commonly the upper eyelid and orbit (<span class="xref-figure">Fig 28-11</span>). Greater involvement of the upper eyelid’s temporal portion results in an S-&#173;shaped configuration. Tumor bulk may cause complete ptosis. Glaucoma in the ipsilateral eye is found in up to 50% of cases.</p>
			<p class="body-text">Complete excision of an eyelid plexiform neurofibroma is generally not pos&#173;si&#173;ble.&#160;Treatment is directed &#173;toward the relief of specific symptoms. Surgical debulking and frontalis suspension procedures can reduce ptosis sufficiently to allow binocular vision. Clinical &#173;trials examining use of biologic agents to treat &#173;these lesions are &#173;under way.</p>
			<p class="body-text"><span class="italic">Optic pathway glioma</span> is a low-&#173;grade pilocytic astrocytoma involving the optic nerve, chiasm, or both. It is pres&#173;ent in approximately 15% of affected patients and is symptomatic in 1%–5% (almost always before age 10&#160;years, &#173;after a period of brief rapid enlargement). The efficacy of treatment (ie, chemotherapy, radiation) is unclear &#173;because of the condition’s highly variable natu&#173;ral history, including relative stability &#173;after rapid growth and spontaneous improvement in a few cases. MRI usually shows cylindrical or fusiform enlargement (<span class="xref-figure">Fig 28-12</span>), often with exaggerated sinuousness or kinking, creating an appearance of discontinuity or localized constriction on axial images. In addition to causing bilateral vision loss, tumors involving primarily the chiasm may result in significant morbidity, including hydrocephalus and hypothalamic dysfunction. Chiasmal glioma in patients with NF1 carries a better prognosis than in individuals without NF1.</p>
			<p class="body-text">Other less common neuroglial abnormalities include spinal and gastrointestinal neurofibromas, pheochromocytomas, prominence of corneal nerves (<span class="symbol CharOverride-1">≤</span>20%), localized orbital neurofibromas, and ret&#173;i&#173;nal hamartomas.</p>
			<p class="reference--journal--single">Jakacki RI, Dombi E, Potter DM, et&#160;al. Phase I trial of pegylated interferon-&#173;α-2b in young patients with plexiform neurofibromas. <span class="italic">Neurology.</span> 2011;76(3):265–272.</p>
			<p class="h3">Other manifestations</p>
			<p class="body-text--no-indent-">Additional manifestations include vari&#173;ous benign tumors that involve the skin or the eye (eg, juvenile xanthogranuloma, ret&#173;i&#173;nal capillary hemangioma), several forms of malignancy (leukemia, rhabdomyosarcoma, pheochromocytoma, Wilms tumor), bony defects such as scoliosis, pseudarthrosis of the tibia, and hypoplasia of the sphenoid bone (which may cause ocular pulsation). Sphenoid dysplasia may be associated with neurofibromas in the ipsilateral superficial temporal fossa as well as in the deep orbit. Several ill-&#173;defined abnormalities of the CNS (macrocephaly, aqueductal stenosis, seizures, and developmental delay) are also seen with greater frequency in patients with NF1. The diagnosis of NF1 should be considered in any child who pres&#173;ents with unilateral glaucoma.</p>
			<p class="body-text">An appropriate interval for periodic ophthalmic reassessment in childhood is 1–2&#160;years, &#173;unless a specific abnormality requires closer observation.</p>
			<p class="reference--journal--first">Fisher MJ, Loguidice M, Gutmann DH, et&#160;al. Visual outcomes in &#173;children with neurofibromatosis type 1–&#173;associated optic pathway glioma following chemother&#173;apy:&#160;a&#160;multicenter retrospective analy&#173;sis. <span class="italic">Neuro Oncol.</span> 2012;14(6):790–797.</p>
			<p class="reference-last--no-space-">Kalamarides M, Acosta MT, Babovic-&#173;Vuksanovic D, et&#160;al. Neurofibromatosis 2011: a report of&#160;the &#173;Children’s Tumor Foundation annual meeting. <span class="italic">Acta Neuropathol.</span> 2012;123(3):369–380.</p>
			<p class="h2">Neurofibromatosis Type 2</p>
			<p class="body-text--no-indent-">Neurofibromatosis type 2 (NF2) is diagnosed clinically by the presence of bilateral acoustic neuromas (eighth cranial nerve tumors) or by a first-&#173;degree relative with NF2 and presence of a unilateral acoustic neuroma, neurofibroma, meningioma, schwannoma, glioma, or early-&#173;onset posterior subcapsular cataract. Patients typically pres&#173;ent in their teens or early adulthood with signs or symptoms related to the eighth nerve tumor(s), including decreased hearing or tinnitus. The most characteristic ocular finding in NF2 is lens opacity, especially posterior subcapsular cataract or wedge-&#173;shaped cortical cataracts. Up to 80% of patients have epiret&#173;i&#173;nal membranes or combined hamartomas of the ret&#173;ina and ret&#173;i&#173;nal pigment epithelium (RPE). Lisch nodules of the iris can occur in NF2 but are infrequent. Salient features are summarized in &#173;Table&#160;28-3.</p>
			<p class="h2">Tuberous Sclerosis</p>
			<p class="body-text--no-indent-">Tuberous sclerosis (TS) is characterized by benign tumor growth in multiple organs, predominantly the skin, brain, heart, kidney, and eye. Prominent extraocular features are summarized in <span class="xref-table">&#173;Table&#160;28-4</span>, with examples shown in <span class="xref-figure">Figures&#160;28-13</span> and <span class="xref-figure">28-14</span>. The classic <span class="italic">Vogt triad</span> of clinical findings is cognitive impairment, seizures, and facial angiofibromas. The facial angiofibromas are not usually pres&#173;ent in young &#173;children, but hypomelanotic macules (“ash-&#173;leaf spots”) are.</p>
			<p class="body-text">The most frequent and characteristic ocular manifestation of TS is ret&#173;i&#173;nal phakoma, frequently termed <span class="italic">astrocytic hamartoma</span> (<span class="xref-figure">Fig 28-15</span>). Pathologically, this growth arises from the innermost layer of the ret&#173;ina and is composed of nerve fibers and relatively undifferentiated cells that appear to be of glial origin. Phakomas are usually found near the posterior pole and involve the ret&#173;ina, the optic disc, or both. They vary in size from approximately half to twice the dia&#173;meter of the disc. Vision is rarely affected.</p>
			<p class="body-text">Ret&#173;i&#173;nal phakomas have 3 distinct appearances. The first is typically found in very young &#173;children; &#173;these phakomas are relatively flat with a smooth surface, indistinct margins, and a gray-&#173;white color that makes them difficult to detect. The second is a sharply demarcated, elevated, yellow-&#173;white, calcified lesion with an irregular surface that has been compared to that of a mulberry. &#173;These lesions are more often found in older patients, on or adjacent to the optic disc. The third type is a transitional lesion that combines features of the first 2.</p>
			<p class="body-text">Phakomas are pres&#173;ent in 30%–50% of patients with TS. One to several phakomas may be found in a single eye, and 40% of cases are bilateral. &#173;There is no evidence that the number of lesions increases with age, but individual tumors have been documented to grow over time. Phakomas are not pathognomonic of TS; they occur occasionally in association with neurofibromatosis and in the eyes of unaffected persons. Ret&#173;i&#173;nal lesions are more common in individuals with mutations in the <span class="italic">TSC2</span> gene. Hypopigmented lesions analogous to ash-&#173;leaf spots are occasionally seen in the iris or choroid.</p>
			<p class="body-text">Management of TS patients by the ophthalmologist includes monitoring of vision and ocular lesions. Difficult-&#173;to-&#173;control seizures respond to vigabatrin: up to 95% of patients experience significant reduction of seizures. However, patients treated with vigabatrin are at risk for ocular complications, which may be difficult or impossible to monitor in patients with TS.</p>
			<p class="reference--journal--single">Aronow ME, Nakagawa JA, Gupta A, Traboulsi EI, Singh AD. Tuberous sclerosis complex: genotype/phenotype correlation of ret&#173;i&#173;nal findings. <span class="italic">Ophthalmology.</span> 2012;119(9):1917–1923.</p>
			<p class="h2">Von Hippel–&#173;Lindau Disease</p>
			<p class="body-text--no-indent-">The ret&#173;i&#173;nal lesions seen in von Hippel–&#173;Lindau disease (VHL; angiomatosis of the ret&#173;ina and cerebellum) and originally described by von Hippel are capillary hemangioblastomas. &#173;These lesions usually become vis&#173;i&#173;ble ophthalmoscopically between ages 10 and 35&#160;years, with an average age at onset of 25&#160;years. Ret&#173;i&#173;nal capillary hemangioblastomas are found in up to 85% of patients with the <span class="italic">VHL</span> mutation. Multiple tumors are pres&#173;ent in the same eye in about one-&#173;third of cases and bilaterally in as many as one-&#173;half of cases. Tumors typically occur in the peripheral fundus, but lesions adjacent to the optic disc have been described. Prominent extraocular features of VHL are summarized in <span class="xref-table">&#173;Table&#160;28-5</span>.</p>
			<p class="body-text">The hallmark of the mature tumor is a pair of markedly dilated vessels (artery and vein) &#173;running between the lesion and the optic disc, indicating significant arteriovenous shunting (<span class="xref-figure">Fig 28-16</span>). Characteristic paired or twin ret&#173;i&#173;nal vessels of normal caliber may be pres&#173;ent before the tumor becomes vis&#173;i&#173;ble.</p>
			<p class="body-text">Histologically, ret&#173;i&#173;nal capillary hemangioblastomas consist of relatively well-&#173;formed capillaries; however, fluorescein angiography shows that &#173;these vessels are leaky. Transudation of fluid into the subret&#173;i&#173;nal space &#173;causes lipid accumulation, ret&#173;i&#173;nal detachment, and consequent vision loss.</p>
			<p class="body-text">Ret&#173;i&#173;nal capillary hemangioblastomas can be effectively treated with cryotherapy or &#173;laser photocoagulation in two-&#173;thirds of cases or more, particularly when the lesions are still small. Antiangiogenic therapy has also shown potential. Early diagnosis increases the likelihood of successful treatment. The ocular lesions of VHL are asymptomatic prior to ret&#173;i&#173;nal detachment. Therefore, &#173;children at risk for the disease should undergo periodic ophthalmologic evaluation beginning at approximately age 5&#160;years.</p>
			<p class="body-text">Early diagnosis of systemic tumors can significantly reduce morbidity and mortality. Molecular ge&#173;ne&#173;tic testing has been suggested for patients with early-&#173;onset (<span class="symbol CharOverride-1">&lt;</span>30&#160;years) cerebellar hemangioblastoma, early-&#173;onset ret&#173;i&#173;nal capillary hemangioblastoma, or familial clear cell renal carcinoma.</p>
			<p class="reference--journal--first">Maher ER, Neumann HP, Richard&#160;S. Von Hippel–&#173;Lindau disease: a clinical and scientific review. <span class="italic">Eur J Hum Genet.</span> 2011;19(6):617–623.</p>
			<p class="reference-last--no-space-">Toy BC, Agr<span class="accent">ó</span>n E, Nigam D, Chew EY, Wong WT. Longitudinal analy&#173;sis of ret&#173;i&#173;nal hemangioblastomatosis and visual function in ocular von Hippel–&#173;Lindau disease. <span class="italic">Ophthalmology.</span> 2012;119(12):2622–2630.</p>
			<p class="h2">Sturge-&#173;Weber Syndrome</p>
			<p class="body-text--no-indent-">Sturge-&#173;Weber syndrome (SWS; encephalofacial angiomatosis) consists of a facial cutaneous vascular malformation (port-&#173;wine stain) with ipsilateral leptomeningeal vascular malformation. Extraocular features are summarized in <span class="xref-table">&#173;Table&#160;28-6</span>, with examples shown in <span class="xref-figure">Figures&#160;28-17</span> and <span class="xref-figure">28-18</span>.</p>
			<p class="body-text">Any portion of the ocular circulation may be anomalous in SWS. When the skin lesion involves the eyelids, increased conjunctival vascularity commonly produces a pinkish discoloration. An abnormal plexus of episcleral vessels is often pres&#173;ent.</p>
			<p class="body-text">The ret&#173;ina sometimes shows tortuous vessels and arteriovenous communications. Choroidal hemangioma is the most significant ret&#173;i&#173;nal anomaly associated with SWS. The tumor is composed of well-&#173;formed choroidal vessels, which give the fundus a uniform deep-&#173;red color that has been compared to that of tomato ketchup (<span class="xref-figure">Fig 28-19</span>). Sometimes only the posterior pole is involved; in other cases, the entire fundus is affected. Choroidal hemangiomas are usually asymptomatic in childhood. During adolescence or adulthood, the choroid sometimes becomes markedly thickened. Degeneration or detachment of the overlying ret&#173;ina may follow. No treatment has been proven to prevent or reverse such deterioration, but scattered application of &#173;laser photocoagulation may help.</p>
			<p class="body-text">Glaucoma is the most common and most serious ocular complication. It has been reported to occur in up to approximately 70% of patients with SWS. &#173;Causes of elevated intraocular pressure (IOP) include elevated episcleral venous pressure, hyperemia of the ciliary body with hypersecretion of aqueous, and developmental anomaly of the anterior chamber &#173;angle. Involvement of the skin of the upper eyelid, choroidal hemangioma, iris heterochromia, and episcleral hemangioma increase the likelihood of glaucoma. Onset of glaucoma can be at birth or &#173;later in childhood.</p>
			<p class="body-text">SWS glaucoma is difficult to treat. Initial therapy with topical eyedrops can be effective, especially in cases of &#173;later onset. Surgery is indicated in early-&#173;onset cases and when medical treatment is inadequate. Adequate long-&#173;term control of IOP can frequently be achieved, but multiple operations are typically necessary. A par&#173;tic&#173;u&#173;lar risk of glaucoma surgery in SWS is intraoperative or postoperative exudation or hemorrhage from anomalous choroidal vessels; this complication is caused by rapid ocular decompression. The surgeon must exercise special care with implanted glaucoma drainage devices to prevent excessive early postoperative hypotony. Postsurgical accumulation of choroidal or subret&#173;i&#173;nal fluid may be dramatic, but spontaneous resorption usually occurs within 1–2 weeks.</p>
			<p class="body-text">&#173;Angle surgery (goniotomy and trabeculotomy) has been used successfully in some patients with SWS. Treatment of affected skin with a pulsed dye &#173;laser has been shown to reduce vascularity, considerably improving appearance without causing significant damage to dermal tissue.</p>
			<p class="reference--journal--single">Khaier A, Nischal KK, Espinosa M, Manoj&#160;B. Periocular port wine stain: the &#173;Great Ormond Street Hospital experience. <span class="italic">Ophthalmology.</span> 2011;118(11):2274–2278.e1.</p>
			<p class="h2">Ataxia-&#173;Telangiectasia</p>
			<p class="body-text--no-indent-">Ataxia-&#173;telangiectasia (AT; Louis-&#173;Bar Syndrome) involves primarily the cerebellum, ocular surface, skin, and immune system. Extraocular features are summarized in <span class="xref-table">&#173;Table&#160;28-7</span>.</p>
			<p class="body-text">Ocular motor abnormalities are found in many patients with AT and are frequently among the earliest manifestations. Characteristically, &#173;there is poor initiation of saccades with preservation of vestibular-&#173;ocular movements, as in congenital ocular motor apraxia. Head thrusts are used to compensate for saccades. Strabismus and nystagmus may also be pres&#173;ent.</p>
			<p class="body-text">Telangiectasia of the conjunctiva occurs in 91% of patients and develops between the ages of 3 and 5&#160;years. Involvement is initially interpalpebral but away from the limbus (<span class="xref-figure">Fig </span><span class="xref-figure">28-20</span>); it eventually becomes generalized. Similar vessel changes can appear in the skin of the eyelids and other sun-&#173;exposed areas.</p>
			<p class="body-text">Individuals with AT are much more sensitive to the tissue-&#173;damaging adverse effects of therapeutic radiation and many chemotherapeutic agents. Defective T-&#173;cell function in patients with AT is usually associated with hypoplasia of the thymus and decreased levels of circulating immunoglobulin. Recurrent respiratory tract infections and increased susceptibility to malignant tumors are frequent &#173;causes of mortality.</p>
			<p class="h2">Incontinentia Pigmenti</p>
			<p class="body-text--no-indent-">Incontinentia pigmenti (IP; Bloch-&#173;Sulzberger syndrome) affects the skin, brain, and eyes. Extraocular features are summarized in <span class="xref-table">&#173;Table&#160;28-8</span>, with examples of skin lesions shown in <span class="xref-figure">Figure&#160;28-21</span>. The condition has an X-&#173;linked dominant inheritance pattern, with a presumed lethal effect on the hemizygous male fetus.</p>
			<p class="body-text">Ocular involvement occurs in 35%–77% of cases and tends to be unilateral or very asymmetric if bilateral, typically in the form of proliferative ret&#173;i&#173;nal vasculopathy that closely resembles retinopathy of prematurity. At birth, the only detectable abnormality may be incomplete peripheral ret&#173;i&#173;nal vascularization. Abnormal arteriovenous connections, microvascular abnormalities, and neovascular membranes develop at or near the junction of the vascular and avascular ret&#173;ina (<span class="xref-figure">Fig 28-22</span>). Rapid progression sometimes leads to total ret&#173;i&#173;nal detachment and retrolental membrane formation within the first few months of life. Microphthalmia, cataract, glaucoma, optic atrophy, strabismus, and nystagmus may occur, usually secondary to end-&#173;stage retinopathy.</p>
			<p class="body-text">Sequential ret&#173;i&#173;nal evaluations for the first 1–2&#160;years of life are necessary to identify eyes that require treatment. The retinopathy of IP has been managed by photocoagulation or cryotherapy with varying degrees of success. Treatment is usually applied primarily to the avascular peripheral ret&#173;ina, as in the management of retinopathy of prematurity.</p>
			<p class="reference--journal--single">O’Doherty M, Mc Creery K, Green AJ, Tuwir I, Brosnahan&#160;D. Incontinentia pigmenti—&#173;ophthalmological observation of a series of cases and review of the lit&#173;er&#173;a&#173;ture. <span class="italic">Br J Ophthalmol.</span> 2011;95(1):11–16.</p>
			<p class="h2">Wyburn-&#173;Mason Syndrome</p>
			<p class="body-text--no-indent-">Wyburn-&#173;Mason syndrome (racemose angioma) is a nonhereditary arteriovenous malformation of the eye and brain. Extraocular features are summarized in <span class="xref-table">&#173;Table&#160;28-9</span>.</p>
			<p class="body-text">Ocular manifestations are unilateral and congenital, and they may pro&#173;gress during childhood. The typical lesion consists of markedly dilated and tortuous vessels that shunt blood directly from arteries to veins (<span class="xref-figure">Fig 28-23</span>). &#173;These vessels do not leak fluid. Vision ranges from normal to markedly reduced. Intraocular hemorrhage and secondary neovascular glaucoma are pos&#173;si&#173;ble complications. More than half of affected eyes are blind, and an additional one-&#173;quarter have severe visual impairment.</p>
			<p class="body-text">No treatment is indicated for primary lesions. Treatment may be considered for associated complications, such as scatter photocoagulation for ischemic venous occlusive disease, vitrectomy for nonclearing vitreous hemorrhage, and cyclodestructive treatment for neovascular glaucoma.</p>
			<p class="h2 ParaOverride-2">Klippel-&#173;Trénaunay Syndrome</p>
			<p class="body-text--no-indent-">Klippel-&#173;Tr<span class="accent">é</span>naunay syndrome (KTS) is a neuro-&#173;oculocutaneous disorder consisting of a vascular nevus involving an extremity, varicosities of that extremity, and hypertrophy of bone and soft tissue. When arteriovenous malformation is also pres&#173;ent, the disease is called <span class="italic">Klippel-&#173;Tr</span><span class="accent_italic">é</span><span class="italic">naunay-&#173;Weber syndrome.</span> Occurrence of KTS is sporadic and the etiology is unknown. Ophthalmic findings include vascular anomalies of the orbit, iris, ret&#173;ina, choroid, and optic nerve, as well as optic nerve and chiasmal gliomas. &#173;There is also a risk of glaucoma.</p>
			<p class="body-text">KTS is a complex syndrome with no single treatment protocol. Treatment is individualized to the patient. At pres&#173;ent, many of the symptoms may be treated, but &#173;there is no cure for this syndrome.</p>
			</div>
			<p class="h1">Albinism</p>
			<div id="Chapt28_Top5">
			<p class="body-text--no-indent-">Albinism is a group of conditions that involve the synthesis of melanin in the skin and eye <span class="italic">(oculocutaneous albinism [OCA])</span> or the eye alone <span class="italic">(ocular albinism [OA]).</span></p>
			<p class="h2 ParaOverride-2">Diagnosis</p>
			<p class="body-text--no-indent-">The major ophthalmic findings in all types of OCA and OA are iris transillumination from decreased pigmentation, foveal aplasia or hypoplasia, and a characteristic deficit of pigment in the ret&#173;ina, especially peripheral to the posterior pole (<span class="xref-figure">Fig 28-24A, B</span>). Nystagmus, photophobia, high refractive errors, and reduced central visual acuity are often pres&#173;ent, and visual acuity ranges from 20/25 to 20/200. If a child has significant foveal hypoplasia, nystagmus &#173;will begin at 2–3 months of age. The severity of the visual impairment tends to be proportional to the degree of nystagmus and foveal hypoplasia. Optical coherence tomography has demonstrated that the size of the photoreceptor outer segment is the strongest predictor of visual acuity. An abnormally large number of crossed fibers appear in the optic chiasm of patients and animals with albinism, precluding stereopsis and often inducing strabismus. Asymmetric visual evoked potentials are often seen in affected patients and may be helpful in diagnosis.</p>
			<p class="body-text">&#173;There are 4 major types of OCA, all of which exhibit vari&#173;ous degrees of skin and hair pigmentation (<span class="xref-figure">Fig 28-24C</span>). They are autosomal recessive and are caused by dif&#173;fer&#173;ent gene mutations (<span class="xref-table">&#173;Table&#160;28-10</span>).</p>
			<p class="body-text">Ocular albinism (OA1), also called <span class="italic">Nettleship-&#173;Falls ocular albinism,</span> is usually caused by a mutation in the <span class="italic">GPR143</span> gene on the X chromosome. This gene controls melanosome number and size; the mutation results in macromelanosomes, which may be revealed by skin biopsy. Affected individuals appear to have decreased pigment in the eyes but not the skin. Patches of decreased pigment in the fundus and iris transillumination are apparent in many female carriers.</p>
			<p class="body-text">Albinism can be part of a broader syndrome, such as Hermansky-&#173;Pudlak syndrome or Ch<span class="accent">é</span>diak-&#173;Higashi syndrome, both of which are autosomal recessive. <span class="italic">Hermansky-&#173;Pudlak syndrome</span> occurs with higher frequency in Puerto Rico and consanguineous populations and is characterized by pulmonary interstitial fibrosis and bleeding abnormalities. <span class="italic">Ch</span><span class="accent_italic">é</span><span class="italic">diak-&#173;Higashi syndrome</span> is a rare condition characterized by increased susceptibility to bacterial infections. Whenever albinism is diagnosed in a child, the clinician should inquire &#173;whether the patient has bleeding or bruising tendencies or experiences frequent infections.</p>
			<p class="reference--journal--first">Khan AO, Tamimi M, Lenzner S, Bolz HJ. Hermansky-&#173;Pudlak syndrome genes are frequently mutated in patients with albinism from the Arabian Peninsula. <span class="italic">Clin Genet.</span> 2016;90(1):96–98.</p>
			<p class="reference--journal--last">Mohammad S, Gottlob I, Kumar A, et&#160;al. The functional significance of foveal abnor&#173;malities in albinism mea&#173;sured using spectral-&#173;domain optical coherence tomography. <span class="italic">Ophthalmology.</span> 2011;118(8):1645–1652.</p>
			<p class="h2">Treatment</p>
			<p class="body-text--no-indent-">Significant refractive errors are treated with prescription glasses. Strabismus surgery is performed when appropriate. Tinted glasses may be used for patients with photophobia. Patients with OCA are at risk for skin cancer and should be counseled about limiting sun exposure.</p>
			<p class="reference--journal--single">Levin AV, Stroh&#160;E. Albinism for the busy clinician. <span class="italic">J AAPOS.</span> 2011;15(1):59–66.</p>
			</div>
			<p class="h1">Diabetes Mellitus</p>
			<div id="Chapt28_Top6">
			<p class="body-text--no-indent-">Type 1, or insulin-&#173;dependent, diabetes mellitus was formerly called <span class="italic">juvenile-&#173;onset diabetes mellitus</span>. The prevalence of retinopathy in this condition is directly proportional to the duration of diabetes mellitus &#173;after puberty. Poor glucose control can cause cataract. Retinopathy rarely occurs less than 15&#160;years &#173;after the onset of diabetes mellitus. Proliferative diabetic retinopathy is rare in pediatric cases (see BCSC Section&#160;12, <span class="italic">Ret&#173;ina and Vitreous</span>). Diabetes mellitus, especially in young &#173;children, may be part of <span class="italic">DIDMOAD syndrome</span> (<span class="italic">d</span>iabetes <span class="italic">i</span>nsipidus, <span class="italic">d</span>iabetes <span class="italic">m</span>ellitus, <span class="italic">o</span>ptic <span class="italic">a</span>trophy, and <span class="italic">d</span>eafness). This condition, which is also known as <span class="italic">Wolfram syndrome,</span> is associated with congenital cataracts as well. BCSC Section&#160;1<span class="italic">, Update on General Medicine,</span> discusses diabetes mellitus in greater detail<span class="italic">.</span></p>
			<p class="body-text">To screen for diabetic retinopathy, the American Acad&#173;emy of Ophthalmology recommends annual ophthalmic examinations beginning 5&#160;years &#173;after the onset of type 1 diabetes mellitus.</p>
			<p class="body-text">Treatment is discussed in BCSC Section&#160;12, <span class="italic">Ret&#173;ina and Vitreous.</span></p>
			<p class="reference--journal--single">American Acad&#173;emy of Ophthalmology Ret&#173;i&#173;na/Vitreous Panel. Preferred Practice Pattern Guidelines. <span class="italic">Diabetic Retinopathy.</span> San Francisco, CA: American Acad&#173;emy of&#160;Ophthalmology; 2017. Available at <a href="http://www.aao.org/ppp"><span class="Hyperlink">www.aao.org/ppp</span></a>.</p>
			</div>
			<p class="h1">Intrauterine or Perinatal Infection</p>
			<div id="Chapt28_Top7">
			<p class="body-text--no-indent-">Maternally transmitted congenital infections cause ocular damage through one or more of the following means: direct action of the infecting agent, which damages tissue; a teratogenic effect, which &#173;causes malformation; or delayed reactivation of the agent &#173;after birth, which damages developed tissue by direct action or inflammation.</p>
			<p class="body-text">Most perinatal disorders have a broad spectrum of clinical pre&#173;sen&#173;ta&#173;tion, ranging from &#173;silent disease to life-&#173;threatening tissue and organ damage. Common, classic types of congenital infections are represented in the mnemonic <span class="italic">TORCH</span>: <span class="italic">to</span>xoplasmosis, <span class="italic">r</span>ubella, &#173;<span class="italic">c</span>ytomegalovirus, and <span class="italic">h</span>erpesviruses.</p>
			<p class="h2">Toxoplasmosis</p>
			<p class="body-text--no-indent-">Systemic infection in &#173;humans by the obligate intracellular parasite <span class="italic">Toxoplasma gondii</span> is common and usually goes undiagnosed. Felines are the definitive host. Signs and symptoms may include fever, lymphadenopathy, and sore throat. The percentage of antibody titer–&#173;positive persons in the United States increases with age (younger than 5&#160;years, 5%; older than 80&#160;years, 60%).</p>
			<p class="body-text">The incidence of congenital toxoplasmosis ranges from 1 to 10 per 10,000 live births. Toxoplasmosis can be acquired congenitally via transplacental transmission from an infected &#173;mother to the fetus. Congenital infection can result in retinitis, hepatosplenomegaly, intracranial calcifications, microcephaly, and developmental delay.</p>
			<p class="body-text">Ocular manifestations besides retinitis include choroiditis, iritis, and anterior uveitis (<span class="xref-figure">Fig 28-25</span>). The area of active ret&#173;i&#173;nal inflammation is usually thickened and cream colored with an overlying vitritis, frequently in the macula. This area may be at the edge of an old, flat, atrophic scar (a so-&#173;called satellite lesion). Previously, apparently acquired <span class="italic">Toxo</span><span class="italic">plasma</span> retinitis was thought to represent reactivation of a congenital infection; however, recent evidence suggests that most of &#173;these patients are infected postnatally. Diagnosis is primarily clinical.</p>
			<p class="body-text">Ocular toxoplasmosis does not require treatment &#173;unless it threatens vision. Systemic treatment involves the use of one or more antimicrobial drugs with or without oral corticosteroids. Commonly used antimicrobial agents are pyrimethamine and sulfadiazine. Corticosteroids should typically be used with antimicrobial coverage. Intravitreal injection of clindamycin and dexamethasone has been reported as a pos&#173;si&#173;ble alternative treatment.</p>
			<p class="body-text">Further details regarding diagnosis and management can be found in BCSC Section&#160;9, <span class="italic">Intraocular Inflammation and Uveitis.</span></p>
			<p class="h2">Rubella</p>
			<p class="body-text--no-indent-">Congenital rubella (German measles) syndrome is a well-&#173;defined combination of ocular, otologic, and cardiac abnormalities, accompanied by microcephaly and variable developmental delay. The incidence has decreased markedly in North Amer&#173;i&#173;ca since widespread vaccination of &#173;children was instituted in the late 1960s; however, rubella remains a cause of infant morbidity and mortality in less-&#173;developed countries.</p>
			<p class="body-text">Ocular abnormalities include a peculiar nuclear cataract that is sometimes floating in a liquefied lens cortex, glaucoma, microphthalmia, and ret&#173;i&#173;nal abnormalities that vary from a subtle salt-&#173;and-&#173;pepper retinopathy (most common finding; <span class="xref-figure">Fig 28-26</span>) to pseudoretinitis pigmentosa. Diagnosis is based on this characteristic clinical picture and is supported by results of serologic testing. The virus itself can be isolated from pharyngeal swabs and from the lens contents at the time of cataract surgery.</p>
			<p class="body-text">Lensectomy is usually required for cataracts. Infected eyes are prone to postoperative inflammation and subsequent secondary membrane formation. Thus, topical ste&#173;roids and mydriatics should be used aggressively. In adults, rubella virus infection has been identified as a probable cause of Fuchs heterochromic uveitis.</p>
			<p class="h2">Cytomegalovirus</p>
			<p class="body-text--no-indent-">Cytomegalovirus (CMV), a member of the herpesvirus &#173;family, is a ubiquitous virus that can cause a wide range of infection, from asymptomatic acquired infection in immunocompetent individuals to severe infections in newborn infants and immunocompromised patients. Over 80% of adults in developed countries have antibodies to the virus.</p>
			<p class="body-text">Congenital infection with CMV is the most common congenital infection in &#173;humans; it occurs in approximately 1% of infants. Clinically apparent disease is pres&#173;ent in 10%–15% of infected neonates, and 20%–30% of &#173;these cases are fatal. Transmission to the fetus or newborn can occur transplacentally, from contact with an infected birth canal during delivery, or from ingestion of infected breast milk or maternal secretions. Congenital CMV disease is characterized by fever, jaundice, hematologic abnormalities, deafness, microcephaly, and periventricular calcifications.</p>
			<p class="body-text">Ophthalmic manifestations of congenital CMV infection occur primarily in infants with systemic symptoms and include retinochoroiditis (<span class="xref-figure">Fig 28-27</span>), optic nerve anomalies, microphthalmia, cataract, and uveitis. The retinochoroiditis usually pres&#173;ents with bilateral focal involvement consisting of areas of RPE atrophy and whitish opacities mixed with ret&#173;i&#173;nal hemorrhages. The retinitis can be progressive, or it may pres&#173;ent as a quiescent CMV chorioret&#173;i&#173;nal scar that is difficult to differentiate from the scar seen in toxoplasmosis. CMV retinitis can be acquired in &#173;children who are immunocompromised (most frequently by infection with HIV or AIDS or following organ transplantation or chemotherapy). The retinitis is a diffuse ret&#173;i&#173;nal necrosis with areas of ret&#173;i&#173;nal thickening and whitening, hemorrhages, and venous sheathing. Vitritis may also be pres&#173;ent.</p>
			<p class="body-text">Diagnosis is based on the clinical pre&#173;sen&#173;ta&#173;tion in acquired disease and is supplemented by serologic testing for antibodies to CMV in congenital infection. In infected infants, the virus can be recovered from bodily secretions.</p>
			<p class="body-text">Infants with severe systemic or sight-&#173;threatening disease are usually treated with ganciclovir. Medi&#173;cations that are available for treatment of older immunocompromised &#173;children include ganciclovir, valganciclovir, foscarnet, cidofovir, and fomivirsen.</p>
			<p class="h2">Herpes Simplex Virus</p>
			<p class="body-text--no-indent-">Herpes simplex virus (HSV) is a member of the herpesvirus &#173;family, which includes 2 types of simplex virus (HSV-1 and HSV-2), herpes zoster, Epstein-&#173;Barr virus, and CMV. Neonatal HSV infection occurs in 1&#160;in 3000 to 20,000 births and is usually secondary to HSV-2. HSV-1 typically affects the eyes, skin, and mouth region and is transmitted by close personal contact. HSV-2 is typically associated with genital infection through venereal transmission.</p>
			<p class="body-text">Congenital HSV infection is usually acquired during passage through an infected birth canal. The neonatal infection is confined to the CNS, skin, oral cavity, and eyes in one-&#173;third of cases. It commonly manifests with vesicular skin lesions, ulcerative mouth sores, and keratoconjunctivitis. Disseminated disease occurs in two-&#173;thirds of cases and can involve the liver, adrenal glands, and lungs. Eye involvement in congenital infection can include conjunctivitis, keratitis, retinochoroiditis, and cataracts. Keratitis can be epithelial or stromal. Ret&#173;i&#173;nal involvement can be severe and may include massive exudates and ret&#173;i&#173;nal necrosis.</p>
			<p class="body-text">Affected infants are treated with systemic acyclovir. The mortality rate from disseminated disease is significant, and survivors usually have permanent ocular and CNS impairment.</p>
			<p class="reference--journal--single">Marquez L, Levy ML, Munoz FM, Palazzi DL. A report of three cases and review of intrauterine herpes simplex virus infection. <span class="italic">Pediatr Infect Dis&#160;J.</span> 2011;30(2):153–157.</p>
			<p class="h2 ParaOverride-3">Syphilis</p>
			<p class="body-text--no-indent-">Syphilis is caused by the spirochete <span class="italic">Treponema pallidum,</span> and sexual contact is the usual route of transmission. Fetal infection occurs following maternal spirochetemia. The longer the &#173;mother has had syphilis, the lower is the risk of transmitting the disease to her child. If a &#173;mother has contracted primary or secondary disease, approximately half of her offspring &#173;will be infected. In cases of untreated late maternal syphilis, approximately 70% of infants are healthy. The incidence of congenital syphilis in the United States is 15.7 cases per 100,000 live births.</p>
			<p class="body-text">Signs and symptoms of congenital syphilis include unexplained premature birth, large placenta, per&#173;sis&#173;tent rhinitis, intractable rash, unexplained jaundice, hepatosplenomegaly, pneumonia, anemia, generalized lymphadenopathy, and metaphyseal abnormalities or periostitis on radiographs. Congenitally acquired infection can lead to neonatal death. Early eye involvement in congenital syphilis is rare.</p>
			<p class="body-text">In some infants, chorioretinitis appears as a salt-&#173;and-&#173;pepper granularity of the fundus. Pseudoretinitis pigmentosa may follow. In rare cases, anterior uveitis, glaucoma, or both may develop. In other cases, signs and symptoms may not appear &#173;until late childhood or adolescence. Widely spaced, peg-&#173;shaped teeth; eighth nerve deafness; and interstitial keratitis constitute the <span class="italic">Hutchinson triad.</span> Other manifestations include &#173;saddle nose, short maxilla, and linear scars around body orifices. Bilateral interstitial keratitis, the classic ophthalmic finding in older &#173;children and adults, occurs in approximately 10% of&#160;patients.</p>
			<p class="body-text">A diagnosis of congenital syphilis is confirmed by identification of <span class="italic">T pallidum</span> by dark-&#173;field microscopy or fluo&#173;rescent antibody testing. The detection of specific immunoglobulin M is currently the most sensitive serologic method.</p>
			<p class="body-text">Congenital syphilis in neonates is treated with intravenous aqueous crystalline penicillin G. Serologic tests are repeated at 2 to 4, 6, and 12 months &#173;after the conclusion of treatment, or &#173;until results become nonreactive or the titer has decreased fourfold. Per&#173;sis&#173;tent positive titers or a positive cerebrospinal fluid VDRL test result at 6 months should prompt retreatment.</p>
			<p class="body-text">Also see BCSC Section&#160;9, <span class="italic">Intraocular Inflammation and Uveitis</span>.</p>
			<p class="reference--non-journal--single">Centers for Disease Control and Prevention. 2016 sexually transmitted diseases sur&#173;veillance:&#160;syphilis. Available at <a href="https://www.cdc.gov/std/stats16/default.htm"><span class="Hyperlink">https://&#173;www.&#173;cdc.&#173;gov/&#173;std/&#173;stats16/&#173;default.&#173;htm</span></a><span class="Hyperlink">. Accessed March 7, 2018.</span></p>
			<p class="h2 ParaOverride-2">Lymphocytic Choriomeningitis</p>
			<p class="body-text--no-indent-">Lymphocytic choriomeningitis virus (LCMV) is an arenavirus that is transmitted by exposure to infected rodents (including &#173;house and laboratory mice and pet hamsters). Infants with congenital LCMV infection pres&#173;ent with CNS abnormalities, including hydrocephaly, microcephaly, intracranial calcifications, and cognitive impairment. Chorioret&#173;i&#173;nal scars, which may involve the entire macula, may occur without neurologic abnormalities. The appearance of &#173;these scars is similar to that of scars seen in patients with toxoplasmosis, CMV infection, and Aicardi syndrome. The diagnosis of LCMV infection should be considered in infants with chorioret&#173;i&#173;nal scars when results of tests for &#173;these more common etiologies are negative. Elevated LCMV antibody titers establish the diagnosis. No specific treatment is available apart from exposure prevention.</p>
			<p class="h2 ParaOverride-2">Zika Virus</p>
			<p class="body-text--no-indent-">Zika virus is a flavivirus transmitted by the <span class="italic">Aedes aegypti</span> mosquito. It has recently been associated with congenital microcephaly and chorioret&#173;i&#173;nal lesions. In a series of 29 infants in Brazil with presumed intrauterine Zika virus infection, ocular abnormalities &#173;were pres&#173;ent in 10 infants (35%) and &#173;were bilateral in 7 infants. The characteristic lesions included posterior pole pigmentary clumping and areas of circumscribed chorioret&#173;i&#173;nal atrophy. In addition, 1 baby showed iris colobomas and lens subluxation. Ce&#173;re&#173;bral visual impairment is common.</p>
			<p class="reference--journal--single">de Paula Freitas B, de Oliveira Dias JR, Prazeres J, et&#160;al. Ocular findings in infants with microcephaly associated with presumed Zika virus congenital infection in Salvador, Brazil. <span class="italic">JAMA Ophthalmol.</span> 2016;134(5):529–535.</p>
			</div>
			<p class="h1 ParaOverride-4">Malignant Disease</p>
			<div id="Chapt28_Top8">
			<p class="h2-h1 ParaOverride-5">Leukemia</p>
			<p class="body-text--no-indent-">Leukemia in childhood is acute in 95% of cases and is more often lymphocytic than &#173;myelocytic. Acute lymphoblastic leukemia is the most common malignant disease of childhood and is responsible for 30% of all cancer cases; &#173;there are 4000 new cases per year in the United States. Although the most common ocular manifestation of leukemia is leukemic retinopathy, all ocular structures can be affected. Ocular involvement is highly correlated with CNS involvement.</p>
			<p class="body-text">Leukemic infiltrates in the anterior segment may lead to heterochromia iridis, a change in the architecture of the iris, frank iris infiltrates, spontaneous hyphemas, leukemic cells in the anterior chamber, and pseudohypopyon. Keratic precipitates may be seen, and glaucoma develops in some affected eyes from tumor cells clogging the trabecular meshwork. Anterior chamber paracentesis for cytologic studies may be diagnostic in cases involving the anterior segment. Systemic chemotherapy, local radiation therapy, and topical ste&#173;roids may be effective for anterior segment complications. Leukemic involvement of the iris may be confused with juvenile xanthogranuloma.</p>
			<p class="body-text">The most common ocular findings are ret&#173;i&#173;nal hemorrhages, especially flame-&#173;shaped lesions in the nerve fiber layer. They involve the posterior fundus and correlate with other aspects of the disease, such as anemia, thrombocytopenia, and coagulation abnormalities. The hemorrhages may have white centers. Ret&#173;i&#173;nal hemorrhages in leukemia can resemble &#173;those associated with abusive head trauma (see Chapter&#160;27), and they have been reported as the first manifestation of leukemia. Other forms of ret&#173;i&#173;nal involvement include localized perivascular infiltrations, microinfarction, and discrete tumor infiltrations. Histologically, the choroid is the most frequently affected ocular tissue, but choroidal involvement is usually not apparent clinically.</p>
			<p class="body-text">Optic nerve involvement occurs if the disc has been infiltrated by leukemic cells (<span class="xref-figure">Fig </span><span class="xref-figure">28-28</span>), which may cause loss of central vision. Translucent swelling of the disc obscures the normal landmarks; with florid involvement, only a white mass is vis&#173;i&#173;ble in the region of the disc. The presence of disc edema and loss of central vision in a child with leukemia should be considered a medical emergency &#173;because permanent loss of central vision is imminent. Such patients should undergo radiation therapy as soon as pos&#173;si&#173;ble.</p>
			<p class="h2">Neuroblastoma</p>
			<p class="body-text--no-indent-">Neuroblastoma is one of the most common childhood cancers and is the most frequent source of childhood orbital metastasis (89% of cases). It usually originates in &#173;either the adrenal gland or the sympathetic ganglion chain in the retroperitoneum or mediastinum. Approximately 20% of all patients with neuroblastoma show clinical evidence of orbital involvement, which is sometimes the initial manifestation of the tumor.</p>
			<p class="body-text">The mean age at diagnosis of patients with metastatic orbital neuroblastoma is approximately 2&#160;years; 90% are diagnosed by 5&#160;years of age. Unilateral or bilateral proptosis and eyelid ecchymosis are the classic pre&#173;sen&#173;ta&#173;tions (<span class="xref-figure">Fig 28-29</span>). Systemic signs and symptoms may include abdominal fullness and pain, venous obstruction and edema, hypertension caused by renal vascular compromise, and bone pain. Urinalysis for catecholamines is positive in 90%–95% of cases.</p>
			<p class="body-text"><span class="italic">Opsoclonus,</span> characterized by rapid, multidirectional saccadic eye movements, is a paraneoplastic syndrome that is associated with neuroblastoma and is not related to orbital involvement. It is associated with a good prognosis for survival, but neurologic deficits may persist. Horner syndrome can occur as a result of a primary cervical or apical thoracic neuroblastoma that involves the sympathetic chain (<span class="xref-figure">Fig 28-30</span>).</p>
			<p class="body-text">Treatment modalities include surgery, chemotherapy, and radiation therapy. Neuroblastoma that pres&#173;ents in a child younger than 1 year has a more favorable prognosis than that in older &#173;children. Approximately 10% of neuroblastomas undergo spontaneous regression.</p>
		</div>
		</div>
		<div id="_idContainer001" class="_idGenObjectStyleOverride-1">
			<table id="table001" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-1" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-3" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table _1-BCSC-table-title" colspan="3">
							<p class="table-title"><span class="table-number">&#173;Table&#160;28-1</span> Common Chromosomal Abnormalities With Ocular Associations</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-5">
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1">
							<p class="table-column-head">Chromosomal Abnormality</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1">
							<p class="table-column-head">Associated Ocular Findings</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table _4-BCSC-table-body-first-row CellOverride-2">
							<p class="table-body"><span class="bold-table">Trisomy 13, Patau syndrome</span></p>
						</td>
						<td class="Basic-Table _4-BCSC-table-body-first-row CellOverride-2" />
						<td class="Basic-Table _4-BCSC-table-body-first-row CellOverride-2">
							<p class="table-body"><span class="table-italic">More common:</span> microphthalmia, coloboma, ret&#173;i&#173;nal dysplasia with frequent islands of intraocular cartilage</p>
							<p class="table-body"><span class="table-italic">Less common:</span> cataract, corneal opacification, cyclopia, per&#173;sis&#173;tent fetal vasculature, shallow supraorbital ridges, upward-&#173;slanting palpebral fissures, absent eyebrows, hypotelorism, hypertelorism, anophthalmia, glaucoma</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-7">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3">
							<p class="table-body"><span class="bold-table">Trisomy 18, Edwards syndrome</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3">
							<p class="table-body"><span class="table-italic">More common:</span> short palpebral fissures, hypertelorism, epicanthus, hypoplastic supraorbital ridge</p>
							<p class="table-body"><span class="table-italic">Less common:</span> cataract, microcornea, corneal opacification, congenital glaucoma, ret&#173;i&#173;nal depigmentation, colobomatous microphthalmia, cyclopia</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3">
							<p class="table-body"><span class="bold-table">Trisomy 21, Down syndrome (most common trisomy)</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3">
							<p class="table-body"><span class="table-italic">More common:</span> epicanthus with upward-&#173;slanting palpebral fissures, blepharitis, Brushfield spots, congenital or acquired cataract, myopia, congenital nasolacrimal duct obstruction and difficulty with probings, ectropion, strabismus, hypoaccommodation, nystagmus, increased number of vessels at optic disc margin</p>
							<p class="table-body"><span class="table-italic">Less common:</span> infantile glaucoma, keratoconus</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3">
							<p class="table-body"><span class="bold-table">Deletion 4p, Wolf-&#173;Hirschhorn syndrome</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3">
							<p class="table-body"><span class="table-italic">More common:</span> colobomatous microphthalmia, epicanthus, downward-&#173;slanting palpebral fissures, hypertelorism, strabismus, ptosis, corneal opacification (Peters anomaly)</p>
							<p class="table-body"><span class="table-italic">Less common:</span> anterior segment anomalies, cataract</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-10">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3">
							<p class="table-body"><span class="bold-table">Deletion 5p, cri-&#173;du-&#173;chat syndrome</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3">
							<p class="table-body"><span class="table-italic">More common:</span> upward-&#173; or downward-&#173;slanting palpebral fissures, hypotelorism or hypertelorism, epicanthus, strabismus</p>
							<p class="table-body"><span class="table-italic">Less common:</span> ptosis, decreased tear production, myopia, cataract, glaucoma, tortuous ret&#173;i&#173;nal vessels, foveal hypoplasia, optic atrophy, colobomatous microphthalmia</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-11">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3">
							<p class="table-body"><span class="bold-table">Deletion 18p</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3">
							<p class="table-body"><span class="table-italic">More common:</span> hypertelorism, ptosis, epicanthus, and strabismus</p>
							<p class="table-body"><span class="table-italic">Less common:</span> cataracts, ret&#173;i&#173;nal dysplasia, colobomatous microphthalmia, synophthalmia/cyclopia</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3">
							<p class="table-body"><span class="bold-table">Deletion 18q</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3">
							<p class="table-body"><span class="table-italic">More common:</span> epicanthus, hypertelorism, downward-&#173;slanting palpebral fissures, strabismus, dysplastic or atrophic optic nerve, nystagmus</p>
							<p class="table-body"><span class="table-italic">Less common:</span> corneal abnormalities, cataracts, blue sclera, myopia, colobomatous microphthalmia</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-12">
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-3">
							<p class="table-body"><span class="bold-table">Monosomy X, Turner syndrome</span></p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-3" />
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-3">
							<p class="table-body"><span class="table-italic">More common:</span> strabismus, ptosis</p>
							<p class="table-body"><span class="table-italic">Less common:</span> cataracts, refractive errors, corneal scars, blue sclera</p>
							<p class="table-body">Incidence of color blindness similar to that in unaffected males</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer004">
				<div id="_idContainer002" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-6715.jpg" alt="" />
				</div>
				<div id="_idContainer003" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-1</span> Bilateral corneal clouding in mucopolysaccharidosis VI. <span class="figure-source-note">(Courtesy of Edward L. Raab, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer007">
				<div id="_idContainer005" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-6706.jpg" alt="" />
				</div>
				<div id="_idContainer006" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-2</span> Cystinosis with corneal involvement. <span class="figure-source-note">(Courtesy of Gregg T. Lueder, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer010">
				<div id="_idContainer008" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-10145.jpg" alt="" />
				</div>
				<div id="_idContainer009" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-3</span> Corneal crystals in a girl with Schnyder corneal dystrophy. <span class="figure-source-note">(Courtesy of Arif O. Khan, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer013">
				<div id="_idContainer011" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-10146.jpg" alt="" />
				</div>
				<div id="_idContainer012" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-4</span> Fleck opacities and posterior capsular cataract secondary to cerebrotendinous xanthomatosis in the right eye of a boy. The patient had a history of intractable infantile diarrhea. <span class="figure-source-note">(Modified with permission from Khan AO, Aldahmesh MA, Mohamed JY, Alkuraya FS. Juvenile cataract morphology in 3 siblings not yet diagnosed with cerebrotendinous xanthomatosis. </span><span class="figure-source-emphasis">Ophthalmology.</span><span class="figure-source-note"> 2013;120(5):956–960.)</span></p>
				</div>
			</div>
		</div>
		<div id="_idContainer014" class="_idGenObjectStyleOverride-1">
			<table id="table002" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-13" />
					<col class="_idGenTableRowColumn-14" />
					<col class="_idGenTableRowColumn-15" />
					<col class="_idGenTableRowColumn-16" />
					<col class="_idGenTableRowColumn-17" />
					<col class="_idGenTableRowColumn-18" />
					<col class="_idGenTableRowColumn-15" />
					<col class="_idGenTableRowColumn-19" />
					<col class="_idGenTableRowColumn-20" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table _1-BCSC-table-title" colspan="9">
							<p class="table-title"><span class="table-number">Table&#160;28-2</span> Ocular Findings in Mucopolysaccharidoses, Mucolipidoses, Lipidoses, Gangliosidoses, and Miscellaneous Disorders</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-4">
							<p class="table-column-head"><span class="CharOverride-2">Disease (code)*</span></p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-4">
							<p class="table-column-head"><span class="CharOverride-2">Enzyme Deficiency</span></p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-4">
							<p class="table-column-head ParaOverride-6"><span class="CharOverride-2">Corneal Clouding</span></p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-4">
							<p class="table-column-head ParaOverride-6"><span class="CharOverride-2">Motility Disorders</span></p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-4">
							<p class="table-column-head ParaOverride-6"><span class="CharOverride-2">Cherry-&#173;Red Spot</span></p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-4">
							<p class="table-column-head ParaOverride-6"><span class="CharOverride-2">Retinal Dystrophy</span></p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-4">
							<p class="table-column-head ParaOverride-6"><span class="CharOverride-2">Optic Atrophy</span></p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-4">
							<p class="table-column-head"><span class="CharOverride-2">Other</span></p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-4">
							<p class="table-column-head ParaOverride-6"><span class="CharOverride-2">Inheritance</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-21">
						<td class="Basic-Table _4-BCSC-table-body-first-row _idGenCellOverride-1" colspan="9">
							<p class="table-head"><span class="CharOverride-2">Mucopolysaccharidosis (MPS) syndromes</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-5">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-7"><span class="CharOverride-2">MPS IH (Hurler) (607014)</span></p>
							<p class="table-body ParaOverride-7"><span class="CharOverride-2">MPS IS (Scheie) (607016)</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="greek--tb- CharOverride-3">α</span><span class="CharOverride-2">-&#173;</span><span class="small-cap CharOverride-2">l</span><span class="CharOverride-2">-&#173;Iduronidase</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+++</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+++</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Glaucoma; plus papilledema (IH only)</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-22">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-7"><span class="CharOverride-2">MPS II (Hunter) (309900)</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Iduronate-2-&#173;sulfatase</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">++</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">XR</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-7"><span class="CharOverride-2">MPS III (Sanfilippo)</span></p>
							<p class="table-body ParaOverride-9"><span class="CharOverride-2">A (252900)</span></p>
							<p class="table-body ParaOverride-9"><span class="CharOverride-2">B (252920)</span></p>
							<p class="table-body ParaOverride-9"><span class="CharOverride-2">C (252930)</span></p>
							<p class="table-body ParaOverride-9"><span class="CharOverride-2">D (252940)</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">A: Heparan </span><span class="table-italic CharOverride-2">N</span><span class="CharOverride-2">-&#173;sulfatase</span></p>
							<p class="table-body"><span class="CharOverride-2">B: </span><span class="greek--tb- CharOverride-3">α</span><span class="CharOverride-2">-&#173;</span><span class="table-italic CharOverride-2">N</span><span class="CharOverride-2">-&#173;Acetyl-&#173;glucosaminidase</span></p>
							<p class="table-body"><span class="CharOverride-2">C: Acetyl-&#173;CoA:</span><span class="greek--tb- CharOverride-3">α</span><span class="CharOverride-2">-&#173;glucosaminide </span><span class="table-italic CharOverride-2">N</span><span class="CharOverride-2">-&#173;acetyltransferase</span></p>
							<p class="table-body"><span class="CharOverride-2">D: </span><span class="table-italic CharOverride-2">N</span><span class="CharOverride-2">-&#173;Acetylglucosamine-6-&#173;sulfatase</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">++</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">Rare</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Late blindness</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-24">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-7"><span class="CharOverride-2">MPS IV (Morquio)</span></p>
							<p class="table-body ParaOverride-9"><span class="CharOverride-2">A (253200)</span></p>
							<p class="table-body ParaOverride-9"><span class="CharOverride-2">B (253010)</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">A: </span><span class="table-italic CharOverride-2">N</span><span class="CharOverride-2">-&#173;Acetyl-&#173;galactosamine-6-&#173;<br />sulfatase</span></p>
							<p class="table-body"><span class="CharOverride-2">B: </span><span class="greek--tb- CharOverride-3">β</span><span class="CharOverride-2">-&#173;Galactosidase</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">++</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">Rare</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">Rare</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">A: AR</span></p>
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">B: AR</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-22">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-7"><span class="CharOverride-2">MPS VI (Maroteaux-&#173;Lamy) (253200)</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Arylsulfatase B</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">++</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Papilledema, glaucoma</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-22">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-7"><span class="CharOverride-2">MPS VII (Sly) (253220)</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="greek--tb- CharOverride-3">β</span><span class="CharOverride-2">-&#173;Glucuronidase</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-25">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3">
							<p class="table-head"><span class="CharOverride-2">Mucolipidoses</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-22">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-7"><span class="CharOverride-2">Type I (256550)</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Neuraminidase</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Hearing loss</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-22">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-7"><span class="CharOverride-2">Sialidosis (glycoproteinosis)</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-5">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-10"><span class="CharOverride-2">“Cherry-&#173;red spot myoclonus <br />syndrome”</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-5">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-7"><span class="CharOverride-2">Type II (252500)</span></p>
							<p class="table-body ParaOverride-9"><span class="CharOverride-2">(I-&#173;cell disease)</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Multiple lysosomal enzymes</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">++</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Hurle</span><span class="CharOverride-2">r</span><span class="CharOverride-2">-&#173;like</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-5">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Type III (252600)</span></p>
							<p class="table-body ParaOverride-9"><span class="CharOverride-2">(pseudo-&#173;Hurler polydystrophy)</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Multiple lysosomal enzymes</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+++</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Hurle</span><span class="CharOverride-2">r</span><span class="CharOverride-2">-&#173;like puffy eyelids</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-22">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-7"><span class="CharOverride-2">Type IV (252650)</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Mucolipin-1 defect</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+++</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">++</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Photophobia</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-22">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-7"><span class="CharOverride-2">Gangliosidosis</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-25">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3">
							<p class="table-head"><span class="CharOverride-2">Lipidoses</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-22">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-7"><span class="CharOverride-2">Niemann-&#173;Pick disease (257220)</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Sphingomyelinase</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">Nystagmus</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Eventual vision loss</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-24">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-7"><span class="CharOverride-2">Fabry disease (301500)</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="greek--tb- CharOverride-3">α</span><span class="CharOverride-2">-&#173;Galactosidase A</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">Whorl-&#173;like</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Angiokeratoma, spokelike cataract, aneurysmal conjunctival vessels</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">XR</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-26">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-7"><span class="CharOverride-2">Gaucher disease</span></p>
							<p class="table-body ParaOverride-9"><span class="CharOverride-2">Type I (230800)</span></p>
							<p class="table-body ParaOverride-9"><span class="CharOverride-2">Type II (230900)</span></p>
							<p class="table-body ParaOverride-9"><span class="CharOverride-2">Type III (231005)</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Acid </span><span class="greek--tb- CharOverride-3">β</span><span class="CharOverride-2">-&#173;glucosidase</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">Paralytic strabismus, looped saccades</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Pinguecula, conjunctival pigmentation</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-5">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Metachromatic leukodystrophy <br />(250100)</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Arylsulfatase A</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">Nystagmus</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Blindness, decreased pupil reaction</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-22">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-7"><span class="CharOverride-2">Krabbe disease (245200)</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Galactosylceramidase</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">Nystagmus</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">Rare</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="CharOverride-2">Cortical blindness</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-27">
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body ParaOverride-7"><span class="CharOverride-2">Fucosidosis (230000)</span></p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body"><span class="greek--tb- CharOverride-3">α</span><span class="CharOverride-2">-&#173;</span><span class="small-cap CharOverride-2">l</span><span class="CharOverride-2">-&#173;Fucosidase</span></p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body"><span class="CharOverride-2">Hurle</span><span class="CharOverride-2">r</span><span class="CharOverride-2">-&#173;like features, angiokeratoma, tortuous conjunctival vessels</span></p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer017" class=" _idGenObjectLayout-2">
				<div id="_idContainer015" class="_idGenObjectStyleOverride-1">
					<table id="table003" class="Basic-Table TableOverride-1">
						<colgroup>
							<col class="_idGenTableRowColumn-13" />
							<col class="_idGenTableRowColumn-28" />
							<col class="_idGenTableRowColumn-29" />
							<col class="_idGenTableRowColumn-30" />
							<col class="_idGenTableRowColumn-31" />
							<col class="_idGenTableRowColumn-32" />
							<col class="_idGenTableRowColumn-17" />
							<col class="_idGenTableRowColumn-33" />
							<col class="_idGenTableRowColumn-34" />
							<col class="_idGenTableRowColumn-35" />
							<col class="_idGenTableRowColumn-36" />
						</colgroup>
						<tbody>
							<tr class="Basic-Table _idGenTableRowColumn-37">
								<td class="Basic-Table _3-BCSC-table-column-head CellOverride-5">
									<p class="table-column-head"><span class="CharOverride-2">Disease (code)*</span></p>
								</td>
								<td class="Basic-Table _3-BCSC-table-column-head CellOverride-5">
									<p class="table-column-head"><span class="CharOverride-2">Enzyme Deficiency</span></p>
								</td>
								<td class="Basic-Table _3-BCSC-table-column-head CellOverride-5">
									<p class="table-column-head ParaOverride-6"><span class="CharOverride-2">Conjunctival Tortuosity</span></p>
								</td>
								<td class="Basic-Table _3-BCSC-table-column-head CellOverride-5">
									<p class="table-column-head ParaOverride-6"><span class="CharOverride-2">Corneal Clouding</span></p>
								</td>
								<td class="Basic-Table _3-BCSC-table-column-head CellOverride-5">
									<p class="table-column-head ParaOverride-6"><span class="CharOverride-2">Motility Disorders</span></p>
								</td>
								<td class="Basic-Table _3-BCSC-table-column-head CellOverride-5">
									<p class="table-column-head ParaOverride-6"><span class="CharOverride-2">Cherry-&#173;Red <br />Spot</span></p>
								</td>
								<td class="Basic-Table _3-BCSC-table-column-head CellOverride-5">
									<p class="table-column-head ParaOverride-6"><span class="CharOverride-2">Retinal Dystrophy</span></p>
								</td>
								<td class="Basic-Table _3-BCSC-table-column-head CellOverride-5">
									<p class="table-column-head ParaOverride-6"><span class="CharOverride-2">Optic Atrophy</span></p>
								</td>
								<td class="Basic-Table _3-BCSC-table-column-head CellOverride-5">
									<p class="table-column-head ParaOverride-6"><span class="CharOverride-2">High Myopia</span></p>
								</td>
								<td class="Basic-Table _3-BCSC-table-column-head CellOverride-5">
									<p class="table-column-head ParaOverride-6"><span class="CharOverride-2">Blindness</span></p>
								</td>
								<td class="Basic-Table _3-BCSC-table-column-head CellOverride-5">
									<p class="table-column-head ParaOverride-6"><span class="CharOverride-2">Inheritance</span></p>
								</td>
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-21">
								<td class="Basic-Table _4-BCSC-table-body-first-row">
									<p class="table-head"><span class="CharOverride-2">Gangliosidoses</span></p>
								</td>
								<td class="Basic-Table _4-BCSC-table-body-first-row" />
								<td class="Basic-Table _4-BCSC-table-body-first-row" />
								<td class="Basic-Table _4-BCSC-table-body-first-row" />
								<td class="Basic-Table _4-BCSC-table-body-first-row" />
								<td class="Basic-Table _4-BCSC-table-body-first-row" />
								<td class="Basic-Table _4-BCSC-table-body-first-row" />
								<td class="Basic-Table _4-BCSC-table-body-first-row" />
								<td class="Basic-Table _4-BCSC-table-body-first-row" />
								<td class="Basic-Table _4-BCSC-table-body-first-row" />
								<td class="Basic-Table _4-BCSC-table-body-first-row" />
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-22">
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-7"><span class="CharOverride-2">Generalized (GM</span><span class="subscript CharOverride-5">1</span><span class="CharOverride-2">) gangliosidoses</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-5">
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-9"><span class="CharOverride-2">Type I (230500)</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-7"><span class="greek--tb- CharOverride-3">β</span><span class="CharOverride-2">-&#173;Galactosidase-1</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">±</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">ET, nystagmus</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">50% of patients</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
								</td>
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-5">
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-9"><span class="CharOverride-2">Type II (230600) (juvenile GM</span><span class="subscript CharOverride-5">1</span><span class="CharOverride-2">, <br />Derry disease)</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-7"><span class="greek--tb- CharOverride-3">β</span><span class="CharOverride-2">-&#173;Galactosidase-1</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">ET, nystagmus</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">±</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">Late</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
								</td>
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-22">
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-9"><span class="CharOverride-2">Type III (230650) (adult GM</span><span class="subscript CharOverride-5">1</span><span class="CharOverride-2">)</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-7"><span class="greek--tb- CharOverride-3">β</span><span class="CharOverride-2">-&#173;Galactosidase-1</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">±</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">Rare</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
								</td>
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-22">
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-7"><span class="CharOverride-2">GM</span><span class="subscript CharOverride-5">2</span><span class="CharOverride-2"> gangliosidoses</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-22">
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-9"><span class="CharOverride-2">Tay-&#173;Sachs disease (272800)</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-5">
								<td class="Basic-Table _5-BCSC-table-body CellOverride-6">
									<p class="table-body ParaOverride-9"><span class="CharOverride-2">Type I (classic infantile)</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-7"><span class="CharOverride-2">Hexosaminidase A</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">Nystagmus, ophthalmoplegia</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
								</td>
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-22">
								<td class="Basic-Table _5-BCSC-table-body CellOverride-6">
									<p class="table-body ParaOverride-9"><span class="CharOverride-2">B1 variant (late infantile)</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-7"><span class="CharOverride-2">HEXA defect</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
								</td>
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-22">
								<td class="Basic-Table _5-BCSC-table-body CellOverride-6">
									<p class="table-body ParaOverride-9"><span class="CharOverride-2">Type III (juvenile subacute)</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-7"><span class="CharOverride-2">Hexosaminidase A or B</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">Strabismus</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
								</td>
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-22">
								<td class="Basic-Table _5-BCSC-table-body CellOverride-6">
									<p class="table-body ParaOverride-9"><span class="CharOverride-2">Chronic adult</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-7"><span class="CharOverride-2">HEXA defect</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">Ocular motor defects</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
								</td>
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-5">
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-9"><span class="CharOverride-2">Type II (268800) <br />(Sandhoff disease)</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-7"><span class="CharOverride-2">Hexosaminidase A <br />and B</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">Rare</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">ET</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">±</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
								</td>
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-38">
								<td class="Basic-Table _5-BCSC-table-body CellOverride-7">
									<p class="table-body ParaOverride-9"><span class="CharOverride-2">Type AB, Hexosaminidase activator deficiency</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body CellOverride-7">
									<p class="table-body ParaOverride-7"><span class="CharOverride-2">Activator deficiency</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body CellOverride-7" />
								<td class="Basic-Table _5-BCSC-table-body CellOverride-7" />
								<td class="Basic-Table _5-BCSC-table-body CellOverride-7">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">Strabismus</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body CellOverride-7">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body CellOverride-7">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body CellOverride-7">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body CellOverride-7" />
								<td class="Basic-Table _5-BCSC-table-body CellOverride-7">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">Late</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body CellOverride-7">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
								</td>
							</tr>
						</tbody>
					</table>
				</div>
				<div id="_idContainer016" class="_idGenObjectStyleOverride-1">
					<table id="table004" class="Basic-Table TableOverride-1">
						<colgroup>
							<col class="_idGenTableRowColumn-13" />
							<col class="_idGenTableRowColumn-39" />
							<col class="_idGenTableRowColumn-30" />
							<col class="_idGenTableRowColumn-40" />
							<col class="_idGenTableRowColumn-30" />
							<col class="_idGenTableRowColumn-41" />
							<col class="_idGenTableRowColumn-42" />
							<col class="_idGenTableRowColumn-43" />
							<col class="_idGenTableRowColumn-36" />
						</colgroup>
						<tbody>
							<tr class="Basic-Table _idGenTableRowColumn-37">
								<td class="Basic-Table _3-BCSC-table-column-head CellOverride-5">
									<p class="table-column-head"><span class="CharOverride-2">Disease (code)*</span></p>
								</td>
								<td class="Basic-Table _3-BCSC-table-column-head CellOverride-5">
									<p class="table-column-head"><span class="CharOverride-2">Enzyme Deficiency</span></p>
								</td>
								<td class="Basic-Table _3-BCSC-table-column-head CellOverride-5">
									<p class="table-column-head ParaOverride-6"><span class="CharOverride-2">Corneal Clouding</span></p>
								</td>
								<td class="Basic-Table _3-BCSC-table-column-head CellOverride-5">
									<p class="table-column-head ParaOverride-6"><span class="CharOverride-2">Motility Disorders</span></p>
								</td>
								<td class="Basic-Table _3-BCSC-table-column-head CellOverride-5">
									<p class="table-column-head ParaOverride-6"><span class="CharOverride-2">Cherry-&#173;Red Spot</span></p>
								</td>
								<td class="Basic-Table _3-BCSC-table-column-head CellOverride-5">
									<p class="table-column-head ParaOverride-6"><span class="CharOverride-2">Retinal Dystrophy</span></p>
								</td>
								<td class="Basic-Table _3-BCSC-table-column-head CellOverride-5">
									<p class="table-column-head ParaOverride-6"><span class="CharOverride-2">Optic Atrophy</span></p>
								</td>
								<td class="Basic-Table _3-BCSC-table-column-head CellOverride-5">
									<p class="table-column-head"><span class="CharOverride-2">Other</span></p>
								</td>
								<td class="Basic-Table _3-BCSC-table-column-head CellOverride-5">
									<p class="table-column-head ParaOverride-6"><span class="CharOverride-2">Inheritance</span></p>
								</td>
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-21">
								<td class="Basic-Table _4-BCSC-table-body-first-row">
									<p class="table-body"><span class="bold-table CharOverride-2">Miscellaneous disorders</span></p>
								</td>
								<td class="Basic-Table _4-BCSC-table-body-first-row" />
								<td class="Basic-Table _4-BCSC-table-body-first-row" />
								<td class="Basic-Table _4-BCSC-table-body-first-row" />
								<td class="Basic-Table _4-BCSC-table-body-first-row" />
								<td class="Basic-Table _4-BCSC-table-body-first-row" />
								<td class="Basic-Table _4-BCSC-table-body-first-row" />
								<td class="Basic-Table _4-BCSC-table-body-first-row" />
								<td class="Basic-Table _4-BCSC-table-body-first-row" />
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-22">
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-7"><span class="CharOverride-2">Galactosialidosis (256540)</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body"><span class="greek--tb- CharOverride-3">β</span><span class="CharOverride-2">-&#173;Galactosidase, neuraminidase</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body"><span class="CharOverride-2">Dwarfism, seizures, coarse facies</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
								</td>
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-22">
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-7"><span class="CharOverride-2">Neuronal ceroid lipofuscinosis</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body" />
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-5">
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-9"><span class="CharOverride-2">CLN1 Infantile Hagberg-&#173;Santavuori disease (256730)</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body"><span class="CharOverride-2">Palmitoyl-&#173;protein thioesterase 1 (PPT-1)</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">Macular</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body"><span class="CharOverride-2">Blindness</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
								</td>
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-5">
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-9"><span class="CharOverride-2">CLN2 Late infantile Hagberg-&#173;Santavuori (204500)</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body"><span class="CharOverride-2">PPT-1</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">Bull’s eye</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body"><span class="CharOverride-2">Blindness</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
								</td>
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-5">
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-9"><span class="CharOverride-2">CLN3 Juvenile Batten, Spielmeye</span><span class="CharOverride-2">r</span><span class="CharOverride-2">-&#173;Vogt disease (204200)</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body"><span class="CharOverride-2">Unknown</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">Bull’s eye</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body"><span class="CharOverride-2">Blindness</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
								</td>
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-22">
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-9"><span class="CharOverride-2">CLN4 Adult Kufs disease (204300)</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body"><span class="CharOverride-2">Unknown</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body" />
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
								</td>
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-22">
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-7"><span class="CharOverride-2">Cystinosis (219800)</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body"><span class="CharOverride-2">Unknown</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">Crystals</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">++</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body"><span class="CharOverride-2">Conjunctival crystals, renal prob&#173;lems</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
								</td>
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-22">
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-7"><span class="CharOverride-2">Galactosemia (230400)</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body"><span class="CharOverride-2">Gal-1-&#173;PO</span><span class="subscript CharOverride-5">4</span><span class="CharOverride-2"> uridyl transferase</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body"><span class="CharOverride-2">Cataracts if not treated</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
								</td>
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-5">
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-7"><span class="CharOverride-2">Mannosidosis (248500)</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body"><span class="greek--tb- CharOverride-3">α</span><span class="CharOverride-2">-&#173;Mannosidase</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">++</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">Pallor, blurred margin</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body"><span class="CharOverride-2">Hurle</span><span class="CharOverride-2">r</span><span class="CharOverride-2">-&#173;like, spokelike cataract</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
								</td>
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-22">
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-7"><span class="CharOverride-2">Homocystinuria (236200)</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body"><span class="CharOverride-2">Cystathionine </span><span class="greek--tb- CharOverride-3">β</span><span class="CharOverride-2">-&#173;synthase</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">+</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body"><span class="CharOverride-2">Dislocated lens, cataract</span></p>
								</td>
								<td class="Basic-Table _5-BCSC-table-body">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
								</td>
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-4">
								<td class="Basic-Table _7-BCSC-table-body-last-row">
									<p class="table-body ParaOverride-7"><span class="CharOverride-2">Refsum disease (266500)</span></p>
								</td>
								<td class="Basic-Table _7-BCSC-table-body-last-row">
									<p class="table-body"><span class="CharOverride-2">Phytanic acid </span><span class="greek--tb- CharOverride-3">α</span><span class="CharOverride-2">-&#173;hydroxylase</span></p>
								</td>
								<td class="Basic-Table _7-BCSC-table-body-last-row">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _7-BCSC-table-body-last-row">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _7-BCSC-table-body-last-row">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _7-BCSC-table-body-last-row">
									<p class="table-body ParaOverride-8"><span class="symbol CharOverride-4">++</span></p>
								</td>
								<td class="Basic-Table _7-BCSC-table-body-last-row">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">–&#173;</span></p>
								</td>
								<td class="Basic-Table _7-BCSC-table-body-last-row">
									<p class="table-body"><span class="CharOverride-2">Cataract, night blindness</span></p>
								</td>
								<td class="Basic-Table _7-BCSC-table-body-last-row">
									<p class="table-body ParaOverride-8"><span class="CharOverride-2">AR</span></p>
								</td>
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-44">
								<td class="Basic-Table _8-BCSC-table-note" colspan="9">
									<p class="table-footnote ParaOverride-7"><span class="CharOverride-2">* Code numbers refer to the system developed by Victor McKusick and colleagues (McKusick VA, Francomano CA, Antonarakis SE. </span><span class="table-italic CharOverride-2">Mendelian Inheritance in Man: Cata&#173;logs of Autosomal Dominant, Autosomal Recessive, and X-&#173;Linked Phenotypes.</span><span class="CharOverride-2"> 10th&#160;ed. Baltimore: The Johns Hopkins University Press; 1992). &#173;Table updates from Online Mendelian Inheritance in Man (</span><a href="http://www.ncbi.nlm.nih.gov/omim"><span class="CharOverride-2">www.&#173;ncbi.&#173;nlm.&#173;nih.&#173;gov/&#173;omim</span></a><span class="CharOverride-2">).</span></p>
								</td>
							</tr>
							<tr class="Basic-Table _idGenTableRowColumn-22">
								<td class="Basic-Table _5-BCSC-table-body" colspan="9">
									<p class="table-footnote"><span class="CharOverride-2">Plus (</span><span class="symbol CharOverride-4">+</span><span class="CharOverride-2">) and minus (–) signs indicate the relative likelihood of occurrence of ocular findings in &#173;these systemic disorders. AR </span><span class="symbol CharOverride-4">=</span><span class="CharOverride-2"> autosomal recessive; ET </span><span class="symbol CharOverride-4">=</span><span class="CharOverride-2"> constant esotropia; XR </span><span class="symbol CharOverride-4">=</span><span class="CharOverride-2"> X-&#173;linked recessive.</span></p>
								</td>
							</tr>
						</tbody>
					</table>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer020">
				<div id="_idContainer018" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-5</span> Lens luxation into the anterior chamber and acute glaucoma as the presenting sign of homocystinuria in a boy. <span class="figure-source-note">(Courtesy of Arif O. Khan, MD.)</span></p>
				</div>
				<div id="_idContainer019" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-10147.png" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer023">
				<div id="_idContainer021" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-10148.png" alt="" />
				</div>
				<div id="_idContainer022" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-6</span> Juvenile retinal dystrophy in a boy with recent slow development of ptosis and ophthalmoplegia, which led to the diagnosis of Kearns-Sayre syndrome. <span class="figure-source-note">(Courtesy of Arif O. Khan, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer024" class="_idGenObjectStyleOverride-1">
				<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-10149.png" alt="" />
			</div>
		</div>
		<div id="_idContainer025" class="Basic-Text-Frame">
			<p class="figure-caption"><span class="figure-number">Figure 28-7</span> This infant with nystagmus related to retinal dystrophy also had polydactyly <span class="figure-caption-italic">(arrow),</span> which led to the diagnosis of Bardet-Biedl syndrome. Systemic features such as renal impairment emerge in later childhood. <span class="figure-source-note">(Courtesy of Arif O. Khan, MD.)</span></p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer028">
				<div id="_idContainer026" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-8</span> Magnetic resonance (MR) image showing the classic “molar tooth” sign in a 2-year-old girl, confirming the diagnosis of Joubert syndrome. The patient presented with developmental delay, retinal dystrophy, and oculomotor apraxia. <span class="figure-source-note">(Courtesy of Arif O. Khan, MD.)</span></p>
				</div>
				<div id="_idContainer027" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-10150.jpg" alt="" />
				</div>
			</div>
		</div>
		<div id="_idContainer029" class="_idGenObjectStyleOverride-1">
			<table id="table005" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-45" />
					<col class="_idGenTableRowColumn-46" />
					<col class="_idGenTableRowColumn-31" />
					<col class="_idGenTableRowColumn-46" />
					<col class="_idGenTableRowColumn-16" />
					<col class="_idGenTableRowColumn-46" />
					<col class="_idGenTableRowColumn-47" />
					<col class="_idGenTableRowColumn-46" />
					<col class="_idGenTableRowColumn-45" />
					<col class="_idGenTableRowColumn-46" />
					<col class="_idGenTableRowColumn-48" />
					<col class="_idGenTableRowColumn-46" />
					<col class="_idGenTableRowColumn-45" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table _1-BCSC-table-title" colspan="13">
							<p class="table-title"><span class="table-number">&#173;Table&#160;28-3</span> Overview and Select Key Features of Neuro-&#173;Oculocutaneous Syndromes</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-49">
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2">
							<p class="table-column-head">Disease</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2">
							<p class="table-column-head">Gene Symbol/Chromosome Location</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2">
							<p class="table-column-head">Inheritance Pattern</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2">
							<p class="table-column-head">Ocular Features</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2">
							<p class="table-column-head">Cutaneous Features</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2">
							<p class="table-column-head">CNS and Other Systemic Features</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2">
							<p class="table-column-head">Incidence and Comments</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-50">
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-body">Neurofibromatosis type 1 (von Recklinghausen disease)</p>
						</td>
						<td class="Basic-Table _4-BCSC-table-body-first-row" />
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-body"><span class="table-italic">NF1</span> (17q11.2); tumor suppressor</p>
						</td>
						<td class="Basic-Table _4-BCSC-table-body-first-row" />
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-body">AD</p>
						</td>
						<td class="Basic-Table _4-BCSC-table-body-first-row" />
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-body">Eyelid neurofibroma, glaucoma, Lisch nodules, optic pathway glioma</p>
						</td>
						<td class="Basic-Table _4-BCSC-table-body-first-row" />
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-body">Caf<span class="tb_accent">é</span>-&#173;au-&#173;lait spots, neurofibromas</p>
						</td>
						<td class="Basic-Table _4-BCSC-table-body-first-row" />
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-body">Sphenoid dysplasia, other tumors</p>
						</td>
						<td class="Basic-Table _4-BCSC-table-body-first-row" />
						<td class="Basic-Table _4-BCSC-table-body-first-row _idGenCellOverride-2" rowspan="2">
							<p class="table-body">1/3500</p>
							<p class="table-body">New mutations common; variable expressivity common</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-51">
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Neurofibromatosis type 2</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="table-italic">NF2</span> (22q12); tumor suppressor</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">AD</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Cataract, retinal com&#173;bined&#160; hamartoma, epiret&#173;i&#173;nal membrane</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Caf<span class="tb_accent">é</span>-&#173;au-&#173;lait spots</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Acoustic neuromas, spinal cord tumors</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">1/33,000</p>
							<p class="table-body">New mutations common</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-52">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Tuberous sclerosis (Bourneville disease)</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="table-italic">TSC1</span> (9q34), <span class="table-italic">TSC2</span> (16p13.3); tumor suppressor</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">AD</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Ret&#173;i&#173;nal astrocytic hamartomas</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Angiofibromas, hypopigmented macules, subungual fibromas</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Seizures, cognitive impairment, renal cell carcinoma, cardiac rhabdomyoma</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">1/10000</p>
							<p class="table-body">New mutations very common</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-53">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-8">
							<p class="table-body">von Hippel–&#173;Lindau disease (ret&#173;i&#173;nal angiomatosis)</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-8" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-8">
							<p class="table-body"><span class="table-italic">VHL</span> (3p26-&#173;p25); tumor suppressor</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-8" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-8">
							<p class="table-body">AD</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-8" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-8">
							<p class="table-body">Ret&#173;i&#173;nal capillary hemangioblastoma</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-8" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-8">
							<p class="table-body">—&#173;</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-8" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-8">
							<p class="table-body">Hemangioblastoma, renal cell carcinoma, pheochromocytoma</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-8" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-8">
							<p class="table-body">1/36000</p>
							<p class="table-body">High penetrance; benign and malignant tumors</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-22">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-9 _idGenCellOverride-3" colspan="13" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table _1-BCSC-table-title" colspan="13">
							<p class="table-title"><span class="table-number">&#173;Table&#160;28-3</span> <span class="CharOverride-6">(continued)</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-49">
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2">
							<p class="table-column-head">Disease</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2">
							<p class="table-column-head">Gene Symbol/Chromosome Location</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2">
							<p class="table-column-head">Inheritance Pattern</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2">
							<p class="table-column-head">Ocular Features</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2">
							<p class="table-column-head">Cutaneous Features</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2">
							<p class="table-column-head">CNS and Other Systemic Features</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-2">
							<p class="table-column-head">Incidence and Comments</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-50">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Sturge-&#173;Weber syndrome (encephalofacial angiomatosis)</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body"><span class="table-italic">GNAQ</span> (9q21)</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Somatic mosaicism</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Diffuse choroidal cavernous angioma, glaucoma</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Nevus flammeus</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Meningeal angiomas, seizures</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">1/50000</p>
							<p class="table-body">Nevus flammeus alone not pathognomonic</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Ataxia-&#173;telangiectasia (Louis-&#173;Bar syndrome)</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="table-italic">ATM</span> (11q22.3)</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">AR</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Saccadic initiation failure, conjunctival telangiectasias</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Telangiectasias</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Cerebellar dysfunction, immunodeficiency, malignancy</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" rowspan="2">
							<p class="table-body">1/40000</p>
							<p class="table-body"><span class="table-italic">ATM</span> is regulator of tumor-&#173;suppressor genes and DNA repair</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-51">
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Incontinentia pigmenti (Bloch-&#173;Sulzberger syndrome)</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="table-italic">IKBKG</span> (Xq28)</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">X-&#173;linked dominant</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Ret&#173;i&#173;nal vasculopathy</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Vesicles with evolution to hyperpigmented lesions</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Seizures, cognitive impairment</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Evolution of skin lesions can occur in utero</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-54">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Wyburn-&#173;Mason syndrome</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Nonhereditary</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Sporadic</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Ret&#173;i&#173;nal racemose angioma</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">If pres&#173;ent, lesions are on face</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Intracranial AVMs with bleeding as sequelae</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Isolated finding more common than syndrome</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-55">
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body">Klippel-&#173;Tr<span class="tb_accent">é</span>naunay-&#173;Weber syndrome</p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row" />
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body">Nonhereditary</p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row" />
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body">Sporadic</p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row" />
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body">Glaucoma</p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row" />
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body">Nevus flammeus similar to that in Sturge-&#173;Weber syndrome</p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row" />
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body">—&#173;</p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row" />
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body">Extremity with vascular nevus, varicosities, hypertrophy of bone and soft tissue, AVM</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-56">
						<td class="Basic-Table _8-BCSC-table-note" colspan="13">
							<p class="table-source-note">AD = autosomal dominant; AR = autosomal recessive; AVM <span class="symbol CharOverride-7">=</span> arteriovenous malformation; CNS = central nervous system.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div id="_idContainer030" class="Basic-Text-Frame">
			<p class="table-unnumbered-list ParaOverride-11"><span class="xref-table CharOverride-8">(Continued)</span></p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer032">
				<div id="_idContainer031" class="Basic-Graphics-Frame _idGenObjectStyleOverride-2">
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer035">
				<div id="_idContainer033" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-10151.jpg" alt="" />
				</div>
				<div id="_idContainer034" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-9</span> Multiple café-au-lait spots in an infant with unilateral glaucoma; neurofibromatosis type 1 (NF1) was ultimately diagnosed. <span class="figure-source-note">(Courtesy of Arif O. Khan, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer038">
				<div id="_idContainer036" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/KIN00811.png" alt="" />
				</div>
				<div id="_idContainer037" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-10</span> Lisch nodules of the iris in 2 patients with NF1. The brown iris has lighter-colored Lisch nodules <span class="figure-caption-bold">(A),</span> whereas the blue iris has darker-colored nodules <span class="figure-caption-bold">(B).</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer041">
				<div id="_idContainer039" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-2382.png" alt="" />
				</div>
				<div id="_idContainer040" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-11</span> Plexiform neurofibroma involving the right upper eyelid, associated with ipsilateral buphthalmos, in a girl with NF1. <span class="figure-caption-bold">A,</span> Age 8 months. <span class="figure-caption-bold">B,</span> Age 8 years.</p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer044">
				<div id="_idContainer042" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-12</span> Axial MR image of a right optic pathway glioma in a child with NF1. <span class="figure-source-note">(Courtesy of Ken K. Nischal, MD.)</span></p>
				</div>
				<div id="_idContainer043" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-6713.jpg" alt="" />
				</div>
			</div>
		</div>
		<div id="_idContainer045" class="Basic-Text-Frame">
			<table id="table006" class="No-Table-Style TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-57" />
					<col class="_idGenTableRowColumn-58" />
					<col class="_idGenTableRowColumn-59" />
				</colgroup>
				<tbody>
					<tr class="No-Table-Style _idGenTableRowColumn-4">
						<td class="No-Table-Style CellOverride-10 _idGenCellOverride-1" colspan="3">
							<p class="table-title"><span class="table-number">Table 28-4</span> Extraocular Features in Tuberous Sclerosis</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-60">
						<td class="No-Table-Style CellOverride-11">
							<p class="table-column-head">Feature</p>
						</td>
						<td class="No-Table-Style CellOverride-11" />
						<td class="No-Table-Style CellOverride-11">
							<p class="table-column-head">Characteristic</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-61">
						<td class="No-Table-Style CellOverride-12">
							<p class="table-body">Ash-leaf spot </p>
						</td>
						<td class="No-Table-Style CellOverride-12" />
						<td class="No-Table-Style CellOverride-12">
							<p class="table-body">Sharply demarcated, hypopigmented skin lesion</p>
							<p class="table-body">Visibility increased by ultraviolet light</p>
							<p class="table-body">Onset during infancy</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-23">
						<td class="No-Table-Style CellOverride-13">
							<p class="table-body">Adenoma sebaceum</p>
						</td>
						<td class="No-Table-Style CellOverride-13" />
						<td class="No-Table-Style CellOverride-13">
							<p class="table-body">Facial angiofibromas </p>
							<p class="table-body">Occurrence in three-quarters of patients</p>
							<p class="table-body">Can be mistaken for acne</p>
							<p class="table-body">Onset during childhood</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-25">
						<td class="No-Table-Style CellOverride-14">
							<p class="table-body">Subungual fibroma </p>
						</td>
						<td class="No-Table-Style CellOverride-14" />
						<td class="No-Table-Style CellOverride-14">
							<p class="table-body">Most common but can be periungual </p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-51">
						<td class="No-Table-Style CellOverride-14">
							<p class="table-body">Shagreen patch</p>
						</td>
						<td class="No-Table-Style CellOverride-14" />
						<td class="No-Table-Style CellOverride-14">
							<p class="table-body">Typically located in lumbosacral area</p>
							<p class="table-body">Onset after puberty</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-23">
						<td class="No-Table-Style CellOverride-14">
							<p class="table-body">Seizures</p>
						</td>
						<td class="No-Table-Style CellOverride-14" />
						<td class="No-Table-Style CellOverride-14">
							<p class="table-body">Periventricular or basal ganglia calcification (representing benign astrocytomas)</p>
							<p class="table-body">Tuberous malformations of the cortex</p>
							<p class="table-body">Cognitive impairment in 50% of patients</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-62">
						<td class="No-Table-Style CellOverride-15">
							<p class="table-body">Other tumors</p>
						</td>
						<td class="No-Table-Style CellOverride-15" />
						<td class="No-Table-Style CellOverride-15">
							<p class="table-body">Cardiac rhabdomyomas </p>
							<p class="table-body">Bone and kidney lesions</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer048">
				<div id="_idContainer046" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-2383.png" alt="" />
				</div>
				<div id="_idContainer047" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-13</span> Cutaneous lesions of tuberous sclerosis. <span class="figure-caption-bold">A,</span> Hypomelanotic macule (ash-leaf spot). <span class="figure-caption-bold">B,</span> Adenoma sebaceum of the face.</p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer051">
				<div id="_idContainer049" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-2210.png" alt="" />
				</div>
				<div id="_idContainer050" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-14</span> Brain lesions of tuberous sclerosis. <span class="figure-caption-bold">A,</span> Axial computed tomography image showing small periventricular calcifications. <span class="figure-caption-bold">B,</span> Axial T2-weighted MR image demonstrating tuberous malformations <span class="figure-caption-italic">(arrows)</span>.</p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer054">
				<div id="_idContainer052" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-2384.png" alt="" />
				</div>
				<div id="_idContainer053" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-15</span> Fundus lesions of tuberous sclerosis, left eye. In addition to the large phakoma partially overlying the optic disc, a small hypopigmented lesion <span class="figure-caption-italic">(arrow)</span> appears in the temporal macula, and a barely visible second phakoma <span class="figure-caption-italic">(arrowhead)</span> partially obscures a retinal blood vessel near the edge of the photograph, directly below the disc. The lesions of tuberous sclerosis can vary considerably in their opaqueness and visibility.</p>
				</div>
			</div>
		</div>
		<div id="_idContainer055" class="Basic-Text-Frame">
			<table id="table007" class="No-Table-Style TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-63" />
					<col class="_idGenTableRowColumn-58" />
					<col class="_idGenTableRowColumn-64" />
				</colgroup>
				<tbody>
					<tr class="No-Table-Style _idGenTableRowColumn-4">
						<td class="No-Table-Style CellOverride-10 _idGenCellOverride-1" colspan="3">
							<p class="table-title"><span class="table-number">Table 28-5</span> Extraocular Features in von Hippel–Lindau Disease</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-60">
						<td class="No-Table-Style CellOverride-11">
							<p class="table-column-head">Feature</p>
						</td>
						<td class="No-Table-Style CellOverride-11" />
						<td class="No-Table-Style CellOverride-11">
							<p class="table-column-head">Characteristic</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-61">
						<td class="No-Table-Style CellOverride-12">
							<p class="table-body">Brain hemangioblastomas</p>
						</td>
						<td class="No-Table-Style CellOverride-12" />
						<td class="No-Table-Style CellOverride-12">
							<p class="table-body">Usually located in cerebellum</p>
							<p class="table-body">Exudation from thin tumor vessel walls causes significant fluid accumulations </p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-54">
						<td class="No-Table-Style CellOverride-13">
							<p class="table-body">Cysts and tumors</p>
						</td>
						<td class="No-Table-Style CellOverride-13" />
						<td class="No-Table-Style CellOverride-13">
							<p class="table-body">Potential for cyst or tumor development in kidneys (renal cell carcinoma), pancreas, liver, epididymis, and adrenal glands (pheochromocytoma)</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-51">
						<td class="No-Table-Style CellOverride-14">
							<p class="table-body">Rare skin lesions</p>
						</td>
						<td class="No-Table-Style CellOverride-14" />
						<td class="No-Table-Style CellOverride-14">
							<p class="table-body">Café-au-lait spots and port-wine stains (nevus flammeus) seen occasionally</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-51">
						<td class="No-Table-Style CellOverride-14">
							<p class="table-body">Shagreen patch</p>
						</td>
						<td class="No-Table-Style CellOverride-14" />
						<td class="No-Table-Style CellOverride-14">
							<p class="table-body">Typically located in lumbosacral area</p>
							<p class="table-body">Onset after puberty</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-23">
						<td class="No-Table-Style CellOverride-14">
							<p class="table-body">Seizures</p>
						</td>
						<td class="No-Table-Style CellOverride-14" />
						<td class="No-Table-Style CellOverride-14">
							<p class="table-body">Periventricular or basal ganglia calcification (representing benign astrocytomas)</p>
							<p class="table-body">Tuberous malformations of the cortex</p>
							<p class="table-body">Cognitive impairment in 50% of patients</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-62">
						<td class="No-Table-Style CellOverride-15">
							<p class="table-body">Other tumors</p>
						</td>
						<td class="No-Table-Style CellOverride-15" />
						<td class="No-Table-Style CellOverride-15">
							<p class="table-body">Cardiac rhabdomyomas</p>
							<p class="table-body">Bone and kidney lesions</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer058">
				<div id="_idContainer056" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-2385.png" alt="" />
				</div>
				<div id="_idContainer057" class="Basic-Text-Frame">
					<p class="figure-caption ParaOverride-6"><span class="figure-number">Figure 28-16</span>  Retinal angiomatosis, left eye, in a patient with von Hippel–Lindau disease.</p>
				</div>
			</div>
		</div>
		<div id="_idContainer059" class="Basic-Text-Frame">
			<table id="table008" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-65" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-66" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table _1-BCSC-table-title" colspan="3">
							<p class="table-title"><span class="table-number">&#173;Table&#160;28-6</span> Extraocular Features in Sturge-&#173;Weber Syndrome</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1">
							<p class="table-column-head">Feature</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1">
							<p class="table-column-head">Characteristics</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-61">
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-body">Port-&#173;wine stain</p>
						</td>
						<td class="Basic-Table _4-BCSC-table-body-first-row" />
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-body">Congenital facial cutaneous vascular malformation (dilatation of the deep dermal plexus)</p>
							<p class="table-body">Hemifacial lesion, typically unilateral</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-67">
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body">Leptomeningeal vascular malformation</p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row" />
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body">Ipsilateral to port-&#173;wine stain</p>
							<p class="table-body">Potentially associated with ce&#173;re&#173;bral calcification (occipital, parietal, temporal, and occasionally frontal lobe), seizures, focal neurologic defect, and highly variable cognitive impairment</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer062">
				<div id="_idContainer060" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-17</span> Axial gadolinium-enhanced T1-weighted MR image shows vascular malformation with underlying cortical atrophy <span class="figure-caption-italic">(arrow)</span> in the left occipital lobe of a 4-month-old girl with Sturge-Weber syndrome.</p>
				</div>
				<div id="_idContainer061" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-2211.png" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer065">
				<div id="_idContainer063" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-18</span> Facial port-wine stain involving the left eyelids, associated with ipsilateral buphthalmos, in an infant girl with Sturge-Weber syndrome and glaucoma.</p>
				</div>
				<div id="_idContainer064" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-2386.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer068">
				<div id="_idContainer066" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-2377.png" alt="" />
				</div>
				<div id="_idContainer067" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-19</span> Fundus appearance in an adolescent boy with Sturge-Weber syndrome. Note the glaucomatous disc cupping and deeper red color of surrounding choroid, right eye <span class="figure-caption-bold">(A),</span> compared with the healthy fellow eye <span class="figure-caption-bold">(B).</span></p>
				</div>
			</div>
		</div>
		<div id="_idContainer069" class="_idGenObjectStyleOverride-1">
			<table id="table009" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-68" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-69" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table _1-BCSC-table-title" colspan="3">
							<p class="table-title"><span class="table-number">&#173;Table&#160;28-7</span> Extraocular Features in Ataxia-&#173;Telangiectasia</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1">
							<p class="table-column-head">Feature</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1">
							<p class="table-column-head">Characteristics</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-70">
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-body">Neurologic findings</p>
						</td>
						<td class="Basic-Table _4-BCSC-table-body-first-row" />
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-body">Truncal ataxia usually noted during second year of life</p>
							<p class="table-body">Subsequent development of dysarthria, dystonia, and choreoathetosis</p>
							<p class="table-body">Progressive deterioration of motor function, leading to serious disability by age 10&#160;years</p>
							<p class="table-body">Intellectual disability and microcephaly in some patients</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Immunologic findings</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Defective T-&#173;cell function is usually associated with hypoplasia of the thymus and decreased levels of circulating immunoglobulin</p>
							<p class="table-body">Recurrent respiratory tract infections (frequent cause of mortality)</p>
							<p class="table-body">Increased susceptibility to malignancy (frequent cause of mortality)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Oncologic findings</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Greatly increased sensitivity to the tissue-&#173;damaging adverse effects of therapeutic radiation and many chemotherapeutic agents</p>
							<p class="table-body">Increased risk of malignancy and radiation damage can also occur in heterozygous carriers</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-62">
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body">Shagreen patch</p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row" />
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body">Typically located in lumbosacral area</p>
							<p class="table-body">Onset &#173;after puberty</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer072">
				<div id="_idContainer070" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-2378.png" alt="" />
				</div>
				<div id="_idContainer071" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-20</span> Abnormally dilated and tortuous interpalpebral conjunctival vessels in a child with ataxia-telangiectasia, seen only in the interpalpebral fissure.</p>
				</div>
			</div>
		</div>
		<div id="_idContainer073" class="_idGenObjectStyleOverride-1">
			<table id="table010" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-71" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-72" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table _1-BCSC-table-title" colspan="3">
							<p class="table-title"><span class="table-number">&#173;Table&#160;28-8</span> Extraocular Features in Incontinentia Pigmenti</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1">
							<p class="table-column-head">Feature</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1">
							<p class="table-column-head">Characteristics</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-body">Dermatologic findings</p>
						</td>
						<td class="Basic-Table _4-BCSC-table-body-first-row" />
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-body">Usually normal skin appearance at birth</p>
							<p class="table-body">Development of erythema and bullae during the first few days of life, usually on the extremities (see Fig 28-21A)</p>
							<p class="table-body">Persistence of lesions for weeks to months</p>
							<p class="table-body">When healed, appearance of lesions as clusters of small, hyperpigmented macules in a characteristic “splashed paint” distribution (see Fig 28-21B), most prominently on the trunk</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-51">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Neurologic findings</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Microcephaly, hydrocephalus, seizures, and varying degrees of cognitive impairment in one-&#173;third of patients</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-25">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Dental findings</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Missing and malformed teeth in roughly two-&#173;thirds of cases</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-62">
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body">Other findings</p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row" />
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body">Scoliosis, skull deformities, cleft palate, and dwarfism, among other findings, occur less commonly</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer076">
				<div id="_idContainer074" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-6719.png" alt="" />
				</div>
				<div id="_idContainer075" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-21</span> Pigmented skin lesions of incontinentia pigmenti. <span class="figure-caption-bold">A,</span> Bullous lesions. <span class="figure-caption-bold">B,</span> Hyperpigmented macules. <span class="figure-source-note">(Courtesy of Edward L. Raab, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer079">
				<div id="_idContainer077" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-2380.jpg" alt="" />
				</div>
				<div id="_idContainer078" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-22</span> Vascular abnormalities of the temporal retina, right eye, in a 2-year-old with incontinentia pigmenti. Note the avascularity peripheral to the circumferential white vasoproliferative lesion, which showed profuse leakage on fluorescein angiography.</p>
				</div>
			</div>
		</div>
		<div id="_idContainer080" class="_idGenObjectStyleOverride-1">
			<table id="table011" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-73" />
					<col class="_idGenTableRowColumn-74" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-75" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table _1-BCSC-table-title" colspan="4">
							<p class="table-title"><span class="table-number">&#173;Table&#160;28-9</span> Extraocular Features in Wyburn-&#173;Mason Syndrome</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1">
							<p class="table-column-head">Feature</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1">
							<p class="table-column-head">Characteristics</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-76">
						<td class="Basic-Table _4-BCSC-table-body-first-row" />
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-body">Dermatologic findings</p>
						</td>
						<td class="Basic-Table _4-BCSC-table-body-first-row" />
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-body">Maxillofacial or cutaneous facial AVM</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-67">
						<td class="Basic-Table _7-BCSC-table-body-last-row" />
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body">Neurologic findings</p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row" />
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body">AVM, especially in midbrain</p>
							<p class="table-body">Frequent source of hemorrhage</p>
							<p class="table-body">May result in seizures, &#173;mental changes, hemiparesis, and <br />papilledema</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer083">
				<div id="_idContainer081" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-23</span> Wyburn-Mason syndrome, or racemose angioma of the retina, left eye.</p>
				</div>
				<div id="_idContainer082" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-2381.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer086">
				<div id="_idContainer084" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-6913.png" alt="" />
				</div>
				<div id="_idContainer085" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-24</span> <span class="figure-caption-bold">A,</span> Transillumination of iris in albinism, right eye. <span class="figure-caption-bold">B,</span> Fundus in albinism, right eye, demonstrating complete lack of pigment and macular hypoplasia. <span class="figure-caption-bold">C,</span> Child with oculocutaneous albinism type 2. Note the white hair, eyebrows, and lashes and light-colored irides and freckles. <span class="figure-source-note">(Parts A and C courtesy of Edward L. Raab, MD.)</span></p>
				</div>
			</div>
		</div>
		<div id="_idContainer087" class="_idGenObjectStyleOverride-1">
			<table id="table012" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-77" />
					<col class="_idGenTableRowColumn-78" />
					<col class="_idGenTableRowColumn-79" />
					<col class="_idGenTableRowColumn-78" />
					<col class="_idGenTableRowColumn-80" />
					<col class="_idGenTableRowColumn-78" />
					<col class="_idGenTableRowColumn-81" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table _1-BCSC-table-title" colspan="7">
							<p class="table-title"><span class="table-number">Table&#160;28-10</span> Classification of Major Types of Oculocutaneous Albinism (OCA)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1">
							<p class="table-column-head">Type of OCA</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1">
							<p class="table-column-head">Defective Gene</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1">
							<p class="table-column-head">Locus</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1">
							<p class="table-column-head">Associated Findings</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-38">
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-body">OCA1A</p>
						</td>
						<td class="Basic-Table _4-BCSC-table-body-first-row" />
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-body">Tyrosinase gene <span class="table-italic">(TYR)</span></p>
						</td>
						<td class="Basic-Table _4-BCSC-table-body-first-row" />
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-body">11q14–&#173;q21</p>
						</td>
						<td class="Basic-Table _4-BCSC-table-body-first-row" />
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-body">White skin and hair; no tyrosinase; poorest vision</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-51">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">OCA1B</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Tyrosinase gene <span class="table-italic">(TYR)</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">11q14–&#173;q21</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">“Yellow variant”; some tyrosinase activity</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-51">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">OCA minimal pigment (MP)</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Tyrosinase gene <span class="table-italic">(TYR)</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">11q14–&#173;q21</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Some tyrosinase activity</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-51">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">OCA temperature-&#173;sensitive</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Tyrosinase gene <span class="table-italic">(TYR)</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">11q14–&#173;q21</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Tyrosine function in cooler areas of body only</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-54">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">OCA2</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body"><span class="table-italic">OCA2</span> gene</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">15q11.2–&#173;q12</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Most prevalent worldwide; seen frequently in African Americans</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">OCA3</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">Tyrosinase-&#173;related protein 1 gene <span class="table-italic">(TYRP1)</span></p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">9p23</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body" />
						<td class="Basic-Table _5-BCSC-table-body">
							<p class="table-body">“Red rufous” type; reddish hair; seen in persons of African descent; mild visual abnormalities</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-49">
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body">OCA4</p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row" />
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body">Membrane-&#173;associated transporter protein gene <span class="table-italic">(MATP)</span></p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row" />
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body">5p13.3</p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row" />
						<td class="Basic-Table _7-BCSC-table-body-last-row">
							<p class="table-body">Common in Japa&#173;nese population</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer090">
				<div id="_idContainer088" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-25</span> Toxoplasmosis chorioretinitis, right eye.</p>
				</div>
				<div id="_idContainer089" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-2274.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer093">
				<div id="_idContainer091" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-26</span> Fundus photograph from a 6-year-old patient with rubella syndrome (electroretinography results were normal).</p>
				</div>
				<div id="_idContainer092" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-2278.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer096">
				<div id="_idContainer094" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-2279.png" alt="" />
				</div>
				<div id="_idContainer095" class="Basic-Text-Frame">
					<p class="figure-caption ParaOverride-6"><span class="figure-number">Figure 28-27</span> Active cytomegalovirus retinochoroiditis in a premature infant, right eye.</p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer099">
				<div id="_idContainer097" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-28</span> Leukemic infiltration of the op-tic nerve.</p>
				</div>
				<div id="_idContainer098" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-2343.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer102">
				<div id="_idContainer100" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-2369.jpg" alt="" />
				</div>
				<div id="_idContainer101" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-29</span> Bilateral orbital metastasis from neuroblastoma in a 2-year-old girl, presenting with periorbital ecchymosis.</p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer105">
				<div id="_idContainer103" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C28_p385-416_final-web-resources/image/AAX-2370.jpg" alt="" />
				</div>
				<div id="_idContainer104" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 28-30</span> Right Horner syndrome, the presenting sign of localized intrathoracic neuroblastoma in a 6-month-old boy.</p>
				</div>
			</div>
		</div>
	</body>
</html>
